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Introduction 
Since domestication of pigs over 5000 years ago in China (Darwin 1868), the modern day 
domestic pig has come a long way. Today, there are over 350 breeds of domestic pigs in 
more than 180 countries (United Nations Environmental Program: http://www.unep.org/).  
During the last three decades many modern reproductive technologies in research such as 
gamete and embryo preservation, in-vitro fertilization, culturing and manipulation of 
embryos, and embryo transfer has boosted the swine industry and helped increase it’s 
productivity (Rothschild and Bidanel 1998). From an economic stand point; increasing 
productivity by manipulation of embryos is not desirable. Even though selection for 
reproductive traits has increased conception rates, 35%-45% of the embryos are lost 
during the first 2-3 week of pregnancy (Pope and First 1985). Therefore, one of the 
primary objectives in the swine industry today is increasing litter size by overcoming 
early embryonic loss during the first 2 – 3 weeks of pregnancy. By increasing litter size 
the incremental cost related to the production of additional pigs are minimal, thus 
substantial gains can be achieved. 
This literature review presents the mapping and expression patterns of human, rat, mouse, 
and pig tissue kallikrein genes. First, the literature review describes what kallikreins are 
and presents the organization and function of tissue kallikreins in humans and other 
animals. Then presents the tissue expression of kallikrein genes, with special emphasis on 
the kallikreins expressed in reproductive tissue.  
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Development in the Pig 
 
During early embryonic development in the pig, initial control of the conceptus occurs 
through maternally derived messages and transcripts until the late four-cell stage of 
development. At the four-cell stage, the embryo takes over development by synthesizing 
its own RNA transcripts while slowly degrading the maternal messages (Tomanek et al. 
1989). By day 10, the embryo forms a blastocyst and starts a unique cellular remodeling 
process leading to conceptus expansion and elongation. At this time the conceptus 
secretes estrogen as the maternal recognition signal of pregnancy and attaches to the 
uterine epithelium forming an epitheliochorial placenta (Geisert et al. 1982a,b & 1997).  
Throughout the 114 day gestation period in the pig, the greatest embryonic loss occurs 
prior to day 25 of pregnancy (Pope and First 1985). This period of embryonic 
development corresponds to critical events involving, conceptus intrauterine migration, 
trophoblastic elongation, establishment of pregnancy, and placental attachment (Geisert 
et al. 1990).  
Unfortunately, little information exists regarding the identity of the gene products and the 
genetic and physiological mechanisms underlying early embryonic development in the 
pig. Understanding and identifying the expression of genes involved with cellular growth, 
differentiation, immuno-protection, and morphological change during conceptus 
development and placental attachment will provide an opportunity to regulate embryo 
development and to possibly improve embryonic survival in the pig. 
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Gene Maps in the Pig  
 
Over the past decade an increasing interest in mapping genes of economic importance in 
farm animals has led to the construction of a fairly dense genetic and physical maps. 
Presently, the porcine genome is among the most well studied farm animal genomes and 
ranks high among mammalian gene maps available today.  
Pig chromosomes generate a special interest to many farm animal cytogeneticists as 
having relatively fewer chromosomes (2n=38) when compared with other farm animal 
species such as cattle (2n=60), sheep (2n=54), goat (2n=60), horse (2n=64), and chicken 
(2n=78) (Chowdhary 1998). Interest in pig cytogenetics has led to unprecedented 
progress in the physical mapping in the pig during the past 3-4 years enabling broader 
understanding of the genome. During the 1990s concerted efforts have helped develop 
comprehensive linkage maps of the porcine genome with contribution from, PiGMaP 
consortium, Nordic collaboration, and the USDA Meat Animal Research Center. These 
combined efforts have placed more than 1500 polymorphic genetic markers on the 
porcine linkage map. These resources have helped animal geneticists and breeders to 
better understand the genetic control of traits critical to agricultural performance such as 
growth, litter size and disease resistance and also to identify individual genes with effects 
on reproductive traits (Chowdhary 1998).     
With the genetic and physical maps showing an almost uniform coverage of the porcine 
genome (Chowdhary 1998) attention is now shifting towards further development of gene 
maps to answer problems of economic significance.  
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What are Kallikreins? 
 
The term “kallikrein” was first introduced in the 1930’s by Werle and colleagues who 
found that high concentrations of kallikrein in the pancreas (in Greek, the “kallikreas”) 
(Yousef and Diamandis 2001, 2003). Since then, the interest in the kallikrein gene family 
has increased tremendously. During the early 1980s extensive research on tissue 
kallikrein gene families of humans and rodents were carried out (Evans et al. 1987), these 
studies have helped us to better understand the structural and functional similarities 
among tissue kallikrein gene family members (See Table 1). 
 
Table 1. Structural similarities among human kallikrein gene family 
members 
  
Structural similarity Reference 
All kallikrein genes code for a putative 
serine proteases with conserved catalytic 
triad (Histidine, Aspartic acid and Serine 
in appropriate positions) 
 
(Yousef and Diamandis 
2001) 
All kallikrein genes have five coding 
exons (some members may contain one or 
more 5’-untranslated exons) 
 
(Yousef and Diamandis 
2001) 
The intron-exons boundaries are conserved 
with the exception of human KLK10 
 
(Yousef and Diamandis 
2001) 
All genes show 40-80% sequence homologies 
at the DNA and amino acid level 
 
(Wines et al. 1989; 
Yousef and Diamandis 
2001),  
Several kallikreins are regulated by 
steroid hormones 
 
(Yousef and Diamandis 
2001) 
Coding exon sizes are similar or identical (Yousef and Diamandis 
2001) 
 
 
Kallikreins are members of a multigene family of serine proteases that are widespread 
throughout living organisms (Gan et al. 2000). They show high degree of substrate 
specificity and have highly diverse physiological functions (Evans et al. 1987). 
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Kallikreins are seen expressed in various tissues and biological fluids (Southardsmith et 
al. 1994; Yousef and Diamandis 2001, 2003) and are involved in functions such as 
fertilization, digestion, regulation of blood flow, blood coagulation, inflammatory 
responses, endothelial cell migration, leukocyte aggregation, tissue remodeling, tumor-
cell invasion and programmed  cell death as well as disease related specialized enzymatic 
activities (Southardsmith et al. 1994; Gan et al. 2000; Cassim et al. 2002; Yousef and 
Diamandis 2003). 
The term “tissue kallikrein” is not restricted to describe enzymes that release kinins 
(bioactive peptides) from precursor molecules, but is used to describe a group of enzymes 
that show high degree of conservation at both gene and protein structure level, and co-
localize or organize into the same chromosomal locus (Evans et al. 1987; Yousef and 
Diamandis 2001 & 2003). Therefore, the term “kallikrein” does not necessarily indicate 
that all family members have the kininogenase activity (Yousef and Diamandis 2003). 
Kallikreins demonstrate similarity at gene and protein level and to some extent at the 
tertiary structure level. Based on the conservation of the primary and tertiary structures  
and the enzymatic activities among the serine proteases, it is hypothesized that all known 
serine proteases arose from a common ancestor through gene and/or chromosomal 
duplication during the course of evolution, which may have caused the serine protease 
gene family to be clustered in the genome (Gan et al. 2000; Yousef and Diamandis 2001). 
The relatively similar sizes of rodent kallikrein gene families suggest that these two 
families of serine proteases may have amplified in the rodent lineage before the 
divergence of rat and the mouse. While the differences in numbers of gene family 
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members among rodents may be due to close linkage of the family, allowing expansion 
and contraction of the gene families leading to unequal crossing over (Wines et al. 1991).  
Comparisons of the kallikrein family members among species reveal that there is a 
greater level of conservation within species than among orthologous genes across species, 
which suggests that  recombination has occurred within a species leading to concerted 
evolution (Wines et al. 1991). Nucleotide differences among kallikreins within a species 
generally exist in single or double nucleotide substitutions, insertions or deletions, but in 
the coding regions, these differences are mostly clustered in short segments of 20bp - 
30bp in length that accommodate up to 12 nucleotide differences in pair-wise comparison 
(Southardsmith et al. 1994).  
Presently the kallikrein gene family is divided into two major subgroups of kallikreins, 
plasma kallikrein which includes just one family member and a larger group of 
kallikreins called the tissue or glandular kallikreins (Gan et al. 2000; Yousef and 
Diamandis 2001 & 2003; Cassim et al,  2002). Plasma and tissue kallikreins differ from 
each other with respect to their molecular weight, isoelectric point, substrate specificity, 
immunological profile, gene structure, expression pattern and type of bioactive peptides 
released (Cassim et al.  2002; Yousef and Diamandis 2001, 2003). 
 
Plasma kallikrein 
 
Plasma kallikrein is secreted by the liver as plasma prekallikrein. In humans, plasma 
kallikrein is encoded by a single gene located on human chromosome 4q34-q35 (Cassim 
et al. 2002; Yu et al. 1998) that is ~22 kb in length (Beaubien et al. 1991). The gene 
coding for plasma kallikrein is composed of 15 exons (Yousef and Diamandis 2001; 
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Cassim et al. 2002) and encodes an enzyme that releases the nano-peptide bradykinin 
upon acting on high molecular weight kininogen (HMWK) (Bhoola et al. 1992; Cassim et 
al. 2002). 
Plasma prekallikrein is a single chain glycoprotein that is released into the circulatory 
system (Cassim et al. 2002). This single chain glycoprotein is found in two forms in 
plasma, as 85 kDa and 88 kDa peptide fragments (Hojima et al. 1985; Veloso and 
Colman 1991). This inactive plasma prekallikrein forms a heterodimer with factor XI to 
its substrate high molecular weight kininogen (Cassim et al. 2002). Following vascular 
damage, HMW kininogen chaperones preplasma kallikrein and Factor XI towards factor 
XII (Hageman factor). Subsequently, Factor XII activates preplasma kallikrein to its 
activated form of plasma kallikrein. Activated plasma kallikrein hydrolyses the Lys-Arg 
and Arg-Ser bonds in high molecular weight kininogen to produce the nano-peptide 
bradykinin (Bhoola et al. 1992; Cassim et al. 2002). 
 
Tissue kallikreins 
 
Tissue kallikreins are acidic glycoproteins with isoelectric points ranging from 3.5 to 4.4 
(Cassim et al. 2002). Their molecular weights range from 25 kDa to 40 kDa (Evans et al. 
1987). Kallikreins show different substrate specificities (Evans et al. 1987). Tissue 
kallikrein 1, which contains the true kininogenase activity, hydrolyzes low molecular 
weight kininogen (LMWK) at the Met-Lys bond at the amino terminal and the Arg-Ser 
bond at the carboxy terminal to release the deca-peptide Lys-bradykinin (Kallidin) 
(Fiedler 1979; Cassim et al. 2002). Later, this deca-peptide Lys-bradykinin is converted 
into bradykinin by amino peptidase (Guimaraes et al 1973).Although LMW-kininogen is 
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the preferred substrate of tissue kallikrein, it can also cleave HMWK to give rise to kinin 
(Carretero and Scicli 1980). 
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Kallikrein gene families in humans and other animals 
 
Human Kallikrein Gene Family 
 
The human kallikrein gene family was first discovered in 1980s. At the time it was 
believed that the human kallikrein gene family was composed of only 3 members, KLK1 
encoding pancreatic/renal kallikrein (Evans et al. 1988), KLK2 encoding human prostate 
glandular kallikrein 2 and KLK3 encoding PSA (Prostate Specific Antigen) (Riegman et 
al. 1989; Yousef and Diamandis 2001; Gan et al. 2000). 
Since then extensive research has been carried out on the kallikrein gene family with  
emphasis on the tissue expression of kallikrein 2 (KLK2) and kallikrein 3 (KLK3), which 
shows potential as candidate biomarkers for tumors and other prostatic diseases 
(Rittenhouse et al. 1998). Currently 15 kallikrein genes have been identified from diverse 
tissues, which co-localize to the same kallikrein gene locus on chromosome 19q13.3 – 
q13.4 (Yousef and Diamandis 2001). These newly identified kallikrein genes share high 
degree of structural similarity. Several of these genes appear to be tumor suppressor 
genes, whereas others are implicated to breast, ovarian and other human cancers (Yousef 
and Diamandis 2001). 
Sequence similarity studies carried out among classical kallikreins (KLK1, KLK2, and 
KLK3) show high similarity (~80%) at protein level, whereas the newly identified 
kallikreins only share 30-50% similarity with the classical kallikreins. Furthermore, the 
distinct “kallikrein loop” that is present in the classical kallikreins is not found in the 
newly identified non-classical human kallikreins (Yousef and Diamandis 2003). 
Differences among human kallikrein gene family members together with the fact that 
only KLK2 and KLK3 of the human kallikrein family does not have any rodent orthologs 
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(Figure 3) suggests that, the newly identified kallikrein genes in the human may have 
diverged after the rodent-primate split between 65 and 85 million years ago (Yousef and 
Diamandis 2003). It is believed that the human kallikrein gene family arose due to gene 
duplication and exon shuffling which might have occurred during unequal crossing over 
of sister chromatids in meiotic recombination (Yousef and Diamandis 2003). 
The human kallikrein gene family can be divided into two main evolutionary families, the 
trypsin-like serine proteases which may have evolved from a single ancestral gene 
through gene duplication to give rise to other genes that gradually mutated with time to 
produce related proteases and protease subfamilies with new functions, and the subtilisin-
like pro-protein convertases, which are assumed to be a product of convergent evolution 
(Yousef and Diamandis 2001). Trypsin-like serine proteases have an aspartic acid residue 
in their binding pocket, which form strong electrostatic bonds with arginine and lysine 
residues. Therefore, this aspartic acid residue is partly responsible for the diverse 
substrate specificity among kallikreins. Among the 15 known human kallikreins, 11 have 
aspartic acid in the binding pocket indicating that these kallikreins may have trypsin-like 
activity. The remaining four kallikreins, KLK3 (serine), KlK7 (asparagines), KLK9 
(glycine), and KLK15 (glutamic acid) are expected to have chymotrypsin-like or other 
specific activity (Yousef and Diamandis 2001).     
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Table 2. Classification of kallikreins based on functional similarity. 
The rat, mouse and human tissue kallikrein gene family members are 
grouped based on their functional similarity (Evens et al. 1987; Wines 
et al. 1989; Yousef and Diamandis 2001). 
Mouse 
kallikreins 
Rat 
kallikreins 
Human 
Kallikreins 
 
FUNCTION 
 
mGK6 rKLK1 or rGK1 KLK1 
True kininogenase activity 
(cleavage of LMW-kininogen to 
Lys-bradykinin 
 
 
rKLK2 or 
rGK2  
Tonin- converts 
angiotensinogen to angiotensin 
 
mGK3   
 
Nerve growth factor binding 
and processing enzyme 
 
Nerve growth factor binding 
and processing enzyme mGK4   
 
 rGK10  Kininogenase activity which cleaves T-kininogen to T-kinin 
 
mGK9   Epidermal growth factor binding protein 
 
Epidermal growth factor 
binding protein mGK13   
 
mGK16   γ- renin 
 
mGK22   Nerve growth factor-inactivating enzyme  
 
mGK26   Prorenin-converting enzyme-2 
 
mGK1,mGK11 
mGK14,mGK21, 
mGK23,mGK25  
rGK3,rGK4, 
rGK5,rGK6, 
rGK7,rGK8 
KLK2,KLK3, 
KLK4,KLK5, 
KLK6,KLK7, 
KLK8,KLK9, 
KLK10,KLK11,
KLK12,KLK13,
KLK14,KLK15 
 
Unknown 
 
mGK2,mGK7, 
mGK10,mGK12, 
mGK15,mGK17, 
mGK18,mGK19, 
mGK23,mGK25 
 
  Pseudogenes 
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Gene Organization of human kallikreins 
 
The sequence information generated around chromosome 19q13.3-q13.4 from the human 
genome project has allowed precise localization of the human kallikrein gene family 
members. This shows that the three classical kallikreins (KLK1, KLK2, and KLK3) are 
clustered within a 60 kb region whereas the newly discovered kallikrein gene, KLK15, 
maps in-between KLK1 and KLK2 (Yousef and Diamandis 2003; Diamandis et al. 2004). 
The remaining kallikreins are localized as shown in figure 1 without any intervention by 
other genes. The direction of transcription of kallikreins is from telomere to centromere 
with the exception of KLK2 and KLK3, which are transcribed from centromere to 
telomere (Yousef and Diamandis 2001). 
All known human kallikreins consists of 5 coding exons and show similar organization 
(Yousef and Diamandis 2001). Unlike classical kallikreins, all other human kallikreins 
have 1-2 exon 5’-untranslated regions. Similarly, 3’-untranslated region among 
kallikreins are variable and give rise to the variants of different mRNA lengths. The 
catalytic triad characteristic to all serine proteases is found in a similar pattern among all 
kallikrein family members, with the second exon harboring histidine, the third exon 
harboring aspartic acid and the fifth exon harboring the serine residue. The protein 
alignment among tissue kallikreins ranges from 40-80% and show the highest similarity 
at the catalytic amino acids histidine, aspartic acid, and serine (Yousef and Diamandis 
2001). 
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Figure 1 
 
Schematic representation of human, mouse and rat tissue kallikrein gene loci. Arrows 
represent genes and point towards the direction of transcription. The three classical 
human glandular kallikrein genes are represented in grey (KLK1) and white (KLK2, 
KLK3). The newly identified human glandular kallikrein genes are represented in black 
(KLK4-15). The paralogs of KLK1 are represented in grey, KLK2 paralogs in white and 
paralogs of KLK4-15 in black. The boundaries of duplicated regions of the rat and mouse 
are shown at the bottom.  
Reproduced from (Olsson et al. 2004).   
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Mouse Kallikrein Gene Family 
 
The mouse kallikrein gene family is the largest family of kallikreins known to date. It 
consists of 24 members among which, 14 encode for active proteins, while the remaining 
are pseudogenes (Evans et al. 1987; Yousef and Diamandis 2001, 2003). The data 
generated by the Mouse Genome Project 
(http://www.ncbi.nlm.nih.gov/genome/guide/mouse) suggests that this number could 
increase up to 37 family members (Yousef and Diamandis 2003). This large family of 
serine proteases in the mouse is localized on chromosome 7, in a ~310 kb region 
corresponding to the Tam-1, Prt-4, and Prt-5 loci (Fig. 2). The human - mouse homology 
maps at NCBI (http://www.ncbi.nlm.nih.gov/Homology) show that this ~310 kb region 
of the mouse kallikrein gene family has conserved synteny to human chromosome 
19q13.4 which harbors the human kallikrein gene family (Yousef and Diamandis 2003). 
All described mouse kallikrein genes share high degree of sequence similarity at mRNA 
and protein level ranging form 70%-90% (Yousef and Diamandis 2003), yet, these family 
members share a great diversity in their function. Among known mouse kallikrein genes, 
only one member (mKLK-1 or mGK6), has true kininogenase activity enabling it to 
cleave LMWK to release bradykinin (Vanleeuwen et al. 1986), while all other known 
kallikrein family members show, diverse physiological functions (see Table 3).  
The mouse kallikrein genes are transcribed in the same direction and share the same 
genomic organization, consisting of five coding exons and four introns, with conserved 
intron-exon splice sites (Yousef and Diamandis 2003). All these kallikreins code for 
prekallikreins that are 261 amino acids long which contain a 18-amino acid signal peptide 
(Yousef and Diamandis 2003).  
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Table 3. Functions of kallikrein family members in the mouse 
GENE FUNCTION 
 
REFERENCE 
 
mGK1 
 
Unknown (Evans et al. 1987) 
mGK2 
 
Pseudogene (Evans et al. 1987) 
mGK3 Nerve growth factor binding and processing enzyme 
 
(Yousef and Diamandis 
2003) 
mGK4 Nerve growth factor binding and processing enzyme 
 
Unknown 
(Yousef and Diamandis 
2003) 
mGK5 
 
True kininogenase activity 
(cleavage of LMW-kininogen to 
Lys-bradykinin 
(Evans et al. 1987) 
mGK6 
 
(Yousef and Diamandis 
2003), (Vanleeuwen et al. 
1986) 
mGK7 Pseudogene 
 
(Evans et al. 1987) 
mGK8 Unknown 
 
(Evans et al. 1987) 
mGK9 Epidermal growth factor binding protein 
 
(Evans et al. 1987) 
mGK10 Pseudogene  (Evans et al. 1987) 
mGK11 Unknown 
 
(Evans et al. 1987) 
mGK12 Pseudogene 
 
(Evans et al. 1987) 
mGK13 Epidermal growth factor binding protein 
(Yousef and Diamandis 
2003) 
 
(Evans et al. 1987) mGK14 Unknown 
 
Pseudogene  mGK15 
 
γ- renin 
(Evans et al. 1987) 
mGK16  
Pseudogene 
(Fahnestock et al. 1991) 
mGK17 
 
Pseudogene 
(Evans et al. 1987) 
mGK18 
 
Pseudogene 
(Evans et al. 1987) 
mGK19 
 
Unknown 
(Evans et al. 1987) 
mGK21 
 
Nerve growth factor-
inactivating enzyme  
(Evans et al. 1987) 
mGK22 
 
(Yousef and Diamandis 
2003) 
mGK23 Pseudogene  (Evans et al. 1987) 
mGK24 Unknown 
 
(Evans et al. 1987) 
mGK25 Pseudogene 
 
(Evans et al. 1987) 
mGK26 Prorenin-converting enzyme-2 (Yousef and Diamandis 2003) 
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Figure  2  
 
The Human – Mouse homology map of mouse chromosome 7. Mouse chromosome 7 
shows conserved synteny to several human chromosomes. Parts of human chromosome 
10 (yellow), 11 (green), 15 (dark-blue), 16 (light-blue), and 19 (purple) shows conserved 
synteny to mouse chromosome 7. Mouse kallikrein gene region is circled in red.  
Reproduced from www.genboree.org   
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Rat Kallikrein Gene Family 
 
The third largest family of kallikreins next to the mouse and the human is the rat 
kallikrein gene family. This gene family consists of 13 family members, among which 10 
code for active genes, while the remaining 3 genes are pseudogenes (Yousef and 
Diamandis 2003; Southardsmith et al. 1994; Wines et al. 1989). But, the data generated 
from the Rat Genome Database (http://ratmap.gen.gu.SE/) suggest that the rat kallikrein 
gene family may be larger (Yousef and Diamandis 2003). 
As in the mouse, the rat kallikrein gene family is clustered together within a single 440 
kb chromosomal region in two clusters. These two kallikrein gene clusters in the rat are 
named as the odd gene cluster and the even gene cluster because all the odd kallikreins 
(rKLK1, rKLK3, rKLK7, rKLK9 ) are localized in one cluster while all the even 
kallikreins (rKLK8, rKLK2, rKLK6, rKLK4, rKLK10) are found in one cluster 
(Southardsmith et al. 1994). The rat –mouse homology map suggests that the rat 
kallikrein gene family may be clustered in chromosome 1 (Fig 3). 
Like in humans and mouse, the rat kallikrein gene family shares high degree of sequence 
homology (>80%) among family members (Wines et al. 1989; Southardsmith et al.  
1994) and codes for active serine proteases which are 261 amino acids in length (see 
table 2). As in the mouse only one rat kallikrein (rKLK1) has the true kininogenase 
activity (Yousef and Diamandis 2003; Ashley and Macdonald 1985) while all other rat 
kallikrein genes are shown to have diverse physiological functions (see table 4). 
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Figure 3 
 
Mouse –Rat homology map of mouse chromosome 7. Mouse chromosome 7 shows high 
conserved synteny to rat chromosome 1 (shown in brown) suggesting that the rat 
kallikrein genes may be clustered in chromosome 1.  
Reproduced from www.genboree.org   
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Table 4. Functions of kallikrein family members in the rat 
 
GENE 
 
 
FUNCTION  
 
REFERENCE 
rKLK1 or rGK1 True kininogenase 
activity. Also known to be 
up-regulated by estrogen.  
 
(Yousef and Diamandis 
2003) 
rKLK2 or rGK2  Tonin- converts 
angiotensinogen to 
angiotensin 
 
(Xiong et al. 1990) 
rGK3 Unknown 
 
(Wines et al. 1989) 
rGK4 Unknown 
 
(Wines et al. 1989) 
rGK5 Unknown 
 
(Wines et al. 1989) 
rGK6 Unknown 
 
(Wines et al. 1989) 
rGK7 Unknown 
 
(Wines et al. 1989) 
rGK8 Unknown 
 
(Wines et al. 1989) 
rGK10 Kininogenase activity 
which cleaves T-kininogen 
to T-kinin. 
(Yousef and Diamandis 
2003) 
 
rGK - rat glandular kallikreins 
rKLK – rat kallikrein 
 
Kallikrein gene families in other species 
 
 
Two kallikreins have been identified in the dog. Where dKLK1 has the true kininogenase 
activity and encodes a 261 amino acid prepropeptide that contains a conserved catalytic 
triad of serine proteases, and a tissue kallikrein substrate binding pocket, while the 
second, (dKLK2), codes for a canine arginine esterase (Chapdelaine et al. 1991). This 
dKLK2 serine protease shows a diverse pattern of tissue expression and only shows about 
50% sequence conservation when compared to kallikreins of other species (Yousef and 
Diamandis 2003). 
Kallikrein genes of the African rodent Mastomys has been studied because of its 
androgen responsive prostate in females (Yousef and Diamandis 2003). The cloning of 
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the kallikreins in Mastomys was first reported by Fahnestock in 1994, where he described 
three kallikreins, two of which are expressed in the kidney and sub-mandibular gland, 
while the 3rd was only expressed in the sub-mandibular gland (Fahnestock et al. 1991). 
Among the 3 kallikreins described one of the two expressed in the kidney is believed to 
code for a true tissue kallikrein which has the kininogenase activity (Fahnestock et al. 
1991).  
A few kallikrein genes in the cynomolgus monkey has been identified by screening a 
kidney cDNA library. These genes show 90% similarity at the nucleotide level and 93% 
similarity at the amino acid level to humans (Lin et al. 1993). A 515 bp long 
preproenzyme KLK3 (rmKLK3) has been cloned from a rhesus monkey prostatic cDNA 
(Gauthier et al. 1993). This KLK3 shows 89% homology to human kallikrein 3 (KLK3) 
and 71% homology to human kallikrein 2 (KLK2) at the amino acid level. The rmKLK3 
lacks the true kininogenase activity as the Tyr93 residue which is essential to the 
kininogenase activity is substituted by a serine residue (Yousef and Diamandis 2003).  
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Why study kallikreins 
With the development of estrous synchronization, superovulation, artificial insemination 
and embryo transfer techniques, attention is now being directed towards understanding 
the mechanisms and regulatory processes that control embryonic survival in the pig. As a 
model species, the pig has many advantages such as a high fertilization rate and relatively 
long gestation period compared to other model species such as the mouse (21 days) 
which provides a better opportunity to study different regulatory mechanisms affecting 
embryonic survival, but having a 35-45 % natural prenatal mortality (Pope and First 
1985) makes pigs an ideal model to study the regulatory mechanisms present during early 
embryonic development to understand the processes that cause early embryonic loss.  
Pregnancy in swine is, typically, initiated with the presence of 14 to 16 viable embryos, 
but only 9 to 10 of these embryos are carried to term. Therefore, understanding the 
mechanisms involved in early embryonic mortality in the pig has an additional economic 
significance, as increasing the litter size by overcoming early embryonic loss would be 
more profitable than improving rate of gain, feed conversion, or lean growth rate (Pope 
and First 1985).  
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Tissue expression and Functions of Kallikreins  
Highly sensitive immunological techniques and RT-PCR has identified kallikrein gene 
expression in a diverse array of tissues. The expression of KLK1 has been shown to be 
high in kidney, pancreas and salivary glands (Yousef and Diamandis 2001). Whereas, 
KLK2 and KLK3 genes are expressed at low concentrations in a wide array of tissues. 
The functional diversity among kallikreins is emphasized by their diverse, tissue specific 
expression patterns. Tissue kallikreins through their multifunctional roles are involved in 
(patho) physiology of brain, kidney, respiratory, gastrointestinal, and reproductive system 
(Bhoola et al. 1992). Table 5 depicts the expression patterns of human tissue kallikreins 
and their proposed functions. 
Until recently, the human kallikrein gene family consisted of only 3 genes (KLK1-3), but 
has now been extended to 15 family members (Yousef and Diamandis 2001). Among the 
various kallikrein gene family members, only KLK1 has the true kininogenase activity to 
produce bradykinin from the proteolytic cleavage of low molecular weight kininogen 
(Guimaraes et al. 1973; Fiedler 1979) which binds to the G-protein coupled kinin 
receptor B to modulate a variety of physiological processors (Luo et al. 2003). This 
release of kinins through the proteolytic cleavage of low molecular weight kininogen has 
recently received increased attention in therapeutic angiogenesis (Emanueli and Madeddu 
2001) suggesting that kinins induce increased microvascular permeability, increased 
blood flow, contraction of smooth muscle, release of calcium and prostaglandins, and 
vascular growth (Bhoola et al. 1992; Fabre et al. 1999), which are many of the alterations 
that occur in the porcine uterus during establishment of pregnancy (Geisert et al. 1997).    
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However, the diverse expression pattern of human kallikrein 1(hK1) has led to the 
suggestion that the functional role of this enzyme is dependent upon cell type (Yousef 
and Diamandis 2001) indicating that apart from its kininogenase activity, hK1 may have 
the ability to process and activate growth factors and peptide hormones (Yousef and 
Diamandis 2001). Also, hK1 is implied as one of the proteinases that participate in the 
process of degrading the extracellular matrix and assisting in the attachment of the 
conceptus to the luminal epithelium (Valdes et al. 2001).  
Lee et al. (1998) reported the presence of an unknown serine protease in the pig uterine 
lumen prior to conceptus elongation which degrades several insulin-like growth factor 
binding proteins (IGFBP). Through its serine protease activity, kallikrein could function 
directly or indirectly through activation of several metalloproteinases to degrade IGFBPs 
(Lee et al. 1998; Vonnahme et al. 1999). Cleavage of  IGFBPs stimulate the release of 
IGF enabling enhanced conceptus growth and estrogen release to establish pregnancy in 
the pig ( Vonnahme et al. 1999; Gerisert et al. 2001).  
Human kallikrein 2 (KLK2) and 3 (KLK3/PSA) are two kallikreins predominantly 
expressed in the prostate, which are used as potential biomarkers for prostate cancer (Luo 
et al. 2003). KLK2 which has trypsin like enzymatic activity, is known to activate 
PSA/KLK3 (Yousef and Diamandis 2001; Luo et al. 2003). Furthermore, KLK2 is 
suggested to play a role in regulating growth factors through IGFBP-3 proteolysis 
(Yousef and Diamandis 2001). Recently, KLK2 was found to activate urokinase 
plasminogen activator (uPA). Since, uPA is involved in the propagation of cancer 
metastasis, KLK2 may be involved in prostate cancer (Yousef and Diamandis 2001). 
KLK3/PSA is the best prostate cancer biomarker discovered thus far, and is widely used 
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in prostate cancer diagnosis (Luo et al. 2003). KLK3 is highly expressed in the seminal 
plasma and has a chymotripsin-like substrate specificity, it cleaves seminogelin I and II , 
as well as fibronectin to liquefy semen clots (Luo et al. 2003 ; Yousef and Diamandis 
2001) in addition to chymotrypsin several other potential substrates such as, IGFBP-3, 
TGFβ, and plasminogen has been identified for KLK3.  
Although enzymatic activities and functional roles for rest of the kallikreins are yet to be 
identified, preliminary studies show that KLK6, KLK8, and KLK11 have trypsin like 
enzymatic activities and KLK7 has chymotrypsin-like enzymatic activity (Luo et al. 
2003). KLK6 is highly expressed in the brain and is implicated to cleave amyloid 
precursor protein indicating it’s involvement in Alzheimer’s disease (Luo et al.  2003).  
KLK7 is shown to be abundantly expressed in the skin, and catalyzes the degradation of 
intracellular cohesive structures in the skin and contribute to the cell shredding process. 
Among the many other known kallikreins, KLK4, KLK5, KLK10, KLK12, KLK13, and 
KLK14 are predicted to have trypsin-like activity, while KLK9 and KLK15 may possess 
chymotrypsin like activity (Yousef and Diamandis 2001; Luo et al. 2003).  
Most of the kallikreins identified today have a potential of being biomarkers for diagnosis 
of various malignancies. KLK8, KLK9, and KLK14 were found to be over-expressed in 
ovarian cancer, while KLK13 was over-expressed in breast cancer  indicating that these 
kallikreins may be used as biomarkers for detection of breast and ovarian cancers. 
Furthermore, KLK10 has been shown to be down-regulated in breast and prostate cancer 
suggesting that KLK10 may function as a tumor suppressor gene (Luo et al. 2003).  
Kallikrein 4 (KLK4), which is also known as prostase, KLK-L1 and PRSS17, has 
recently received increase attention as a potential biomarker in endometrial cancer, the 
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fourth most common malignancy in women in the western world (Mayers and Clements 
2001). KLK 4 is thought to be regulated by estrogen and progesterone individually and 
synergistically (Mayers and Clements 2001). Interestingly, KLK4 is expressed in the 
KLE cell line which has a defective estrogen receptor (ER) (Mayers and Clements 2001). 
This suggests that an indirect mechanism of response, or a non-genomic steroid response 
through a membrane bound receptor may be present for kallikrein 4 stimulation (Mayers 
and Clements 2001). The biological function of KLK4 is yet to be identified; however 
human kallikrein 4 shares a 78 % homology at the amino acid level with pig enamel 
matrix serine protease (EMSP1/KLK4) which is involved in the degradation of the 
enamel protein matrix allowing the maturation of the dental enamel, suggesting that 
KLK4 may play a role in extracellular matrix remodeling in the uterus (Mayers and 
Clements 2001).  
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Table 5. Expression patterns of the human kallikrein gene family. The 
highly expressed tissues are in bold. Reproduced from (Yousef and 
Diamandis 2001). 
GENE TISSUE EXPRESSION 
 
FUNCTION /DISEASE 
 
KLK1 Pancreas, kidney, salivary glands, 
central nervous system (CNS), uterus, 
prostate, testis, breast, placenta 
Inflammation, renal 
disease, and cancer, 
mediates, bradykinin  
 
KLK2 Prostate, breast, thyroid, salivary 
glands 
Biomarker for prostate 
cancer 
 
Favorable biomarker for 
prostate and breast cancer 
KLK3 Prostate, breast, thyroid, salivary 
glands, lung, trachea  
 
Over expressed in ovarian 
cancer 
KLK4 Prostate, breast, thyroid, testis, 
uterus, adrenal, colon, spinal cord 
 
Over expressed in ovarian 
cancer 
KLK5 Breast, brain, testis, skin, salivary 
glands, thymus, CNS, prostate, 
thyroid, trachea 
 CNS, breast, kidney, uterus, salivary 
glands, spleen, testis  
KLK6 Down-regulated in breast 
cancer 
 
Over expressed in 
pathological 
keratinization, psoriasis 
and ovarian cancer 
KLK7 Skin, CNS, kidney, breast, salivary 
glands, thymus, uterus, thyroid, 
placenta, trachea, testis, ovary  
 
Over expressed in CNS 
injury 
KLK8 CNS, skin, ovary 
 
Unknown KLK9 Thymus, testis, CNS, trachea, breast, 
prostate, salivary glands, ovary, 
skin 
 Breast, ovary, testis, prostate, 
small intestine, lung, colon, 
pancreas, uterus, CNS, salivary 
glands, trachea 
KLK10 
 Brain, skin, salivary glands, 
stomach, uterus, lung, thymus, 
prostate, spleen liver, small 
intestine, trachea, heart, fetal 
liver, breast, thyroid, skeletal 
muscle 
Down regulated in breast 
and prostate cancer 
KLK11 
 Salivary glands, stomach, uterus, 
trachea, prostate, thymus, lung, 
colon, brain, breast thyroid, testis, 
pancreas, small intestine, spinal 
cord 
Unknown 
KLK12 
 Breast, prostate, salivary glands, 
testis, lung, heart, thymus, adrenal, 
colon, thyroid, trachea 
Down-regulated in breast 
cancer 
KLK13 
 CNS, breast, thyroid, uterus, thymus 
colon, spleen, placenta, small 
intestine, kidney, bone marrow 
Down-regulated in breast 
cancer 
KLK14 
 Thyroid, salivary glands, prostate, 
adrenal, colon, testis, kidney 
Down-regulated in breast 
cancer 
KLK15 
 
Over expressed in prostate 
cancer 
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Kallikreins in Reproduction 
Previous studies show that the kallikrein-kininogen-kinin system is involved during 
mediation of reproductive events in the rat (Gao et al. 1992). In the rat, the kallikrein-
kininogen-kinin system is activated in the ovary during the time of ovulation (Brann et al. 
1995). Activation of the kallikrein-kininogen-kinin system in the rat ovary is 
physiologically important as the administration of kinin antagonists have shown to block 
ovulation (Hellberg et al. 1991; Brann et al. 1995) indicating that the kinin system plays 
an important role during ovulation in the rat (Valdes et al. 1996). Also, “tissue kallikrein 
mRNA and the corresponding protein (rK1), as well as the type 2 bradykinin receptor, 
has been immunolocalized in luminal and glandular epithelium, implantation node, 
deciduomata, and sub-placental sinusoids” in the rat   indicating that the kallikrein-
kininogen-kinin system is active during early embryonic development in the rat (Valdes 
et al. 2001).   
In the mouse, 5 kallikreins (KLK1, KLK3, KLK5, KLK9, KLK21) are implicated to play 
a major role in uterine physiological functions and during embryo implantation (Valdes et 
al. 1996; Corthorn et al. 1997; Chan et al. 1999) where the function of KLK5 and KLK21 
are unknown, and   KLK1, KLK3 and KLK9  encodes for tissue kallikrein, γ-nerve 
growth factor binding protein (NGF-BP) and epidermal growth factor binding protein 
(EGF-BP) respectively (Chan et al. 1999).  
It is believed that embryo implantation is tightly regulated by the release of proteinases 
such as matrix metalloproteinases (MMPs) and urokinase plasminogen activator 
(Behrendtsen et al. 1992; Harvey et al. 1995) that degrade the extra cellular matrix, 
enabling conceptus invasion into the uterine stroma. Kallikreins have been implicated to 
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code for proteins that activate a wide range of substrates including extracellular matrix 
proteinases and growth factors (Chan et al. 1999), suggesting that kallikreins are involved 
in many integral processors of early embryonic development such as regulation of local 
blood flow, angiogenesis, tissue invasion, and mitogenesis (Bhoola et al. 1992).   
In humans, the uterine localization of tissue kallikrein mRNA and protein as well as type 
2 bradykinin receptor to key sites of embryo attachment, implantation and placentation, 
supports the notion that the kallikrein-kininogen-kinin system plays a role during 
pregnancy, probably through vasodilation, increased vasopermeability, enhanced matrix 
degradation, stimulation of cell proliferation, and myometrial contractility. The higher 
expression of tissue kallikrein 1 mRNA and protein in the trophoblast and fetal 
endometrium during early pregnancy  indicates that like in the rat and mouse the 
kallikrein-kininogen- kinin plays a major role during early embryonic development in 
humans (Valdes et al. 2001). 
In the pig, tissue kallikrein enzymatic activity, protein, and gene expression has been 
detected during the estrous cycle and early conceptus development. An increase in 
kallikrein enzymatic activity on day 12 of pregnancy in the pig has been detected 
(Vonnahme et al. 1999). This increase in enzymatic activity occurs simultaneously with 
the loss of uterine epithelial progesterone receptor, rapid trophoblastic elongation and 
conceptus estrogen release indicating that the kallikrein release may assist in conceptus 
attachment through possibly degradation of IαIH4 (Vonnahme et al. 1999). It is 
hypothesized that, following down-regulation of uterine epithelial progesterone receptor, 
MUC-1 gene expression is reduced (Bowen et al. 1996), enabling the conceptus to 
interact with integrins, proteoglycans and heparin, while the cleavage of IαIH4 by 
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kallikreins may assist in conceptus attachment (Vonnahme et al. 1999). Porcine kallikrein 
1 cleaves IαIH4 into 100 kDa and 35 kDa fragments, where the 100 kDa fragment is 
further cleaved into a 70 kDa fragment (Vonnahme et al. 1999). During conceptus 
elongation and attachment a 30 kDa fragment corresponding to the C-terminal of IαIH4 
has been detected within the uterine lumen  suggesting that kallikreins may help regulate 
alterations in IαIH4 necessary for conceptus attachment and placental development 
(Geisert et al. 1995; Vonnahme et al. 1999) in the pig.  
The localization of bradykinin β2 receptor in the rat (Murone et al. 1999; Figueroa et al.  
2001) sheep ( Murone et al. 1996), human (Valdes et al. 2001; Hecquet et al. 2000) and 
the pig (Allen et al. 2002) uterus and the detection of kallikrein activity also suggests that 
the kallikrein-kininogen-kallikrein system is functional during pregnancy. In addition, the 
expression of low molecular weight kininogen (Vonnahme et al. 2003), and pregnancy 
specific increase of bradykinin (Allen et al.2002) in the porcine uterus during early 
gestation further suggests that the kallikrein-kininogen-kallikrein system is active in the 
pig.  
Although previous studies have shown tissue kallikrein gene expression in cyclic and 
pregnant gilts (Vonnahme et al. 1999), it is not clear whether kallikrein gene expression 
is due to activation of prekallikrein or due to altered gene expression. Therefore, further 
studies are necessary to determine whether kallikrein gene expression is altered during 
the estrous cycle and early pregnancy or if the changes in kallikrein gene expression is 
due to activation of kallikrein activity from prekallikrein (Vonnahme et al. 1999).  
Even though preliminary data demonstrates the involvement of kallikreins in uterine 
events during early embryonic development, expression of specific members of this large 
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family has not been fully characterized, only porcine kallikrein 4 KLK4 which was 
isolated from the dental enamel is known (Ryu et al. 2002). Therefore as a first step 
towards understanding the functional role of tissue kallikreins during early embryonic 
development in the pig, we have constructed a BAC clone based physical map of the 
greater kallikrein region in the pig and have mapped the kallikrein region to porcine 
chromosome 6q1.2 with high confidence. We have also initiated the sequence analysis of 
the whole kallikrein gene region in the pig and have isolated several new porcine tissue 
kallikreins. Further more, we have analyzed the differential expression of 3 tissue 
kallikreins (KLK1, KLK4 and KLK14) during early embryogenesis in both maternal and 
fetal tissue to better understand the functional role of tissue kallikreins during early 
embryonic development in the pig. 
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Introduction  
During early pregnancy in the pig, the conceptus undergoes rapid trophoblastic 
elongation from a 10 mm sphere to a long filamentous thread like structure (Geisert et al. 
1982a,b). This morphological alteration on Day 12 occurs concurrently with the 
establishment of pregnancy in the pig (Bazer et al. 1982; Geisert and Yelich 1997). On 
day 12 of pregnancy, the conceptus synthesizes and releases estradiol-17β during the 
rapid trophoblastic elongation phase as the maternal recognition signal for establishment 
and maintenance of pregnancy (Geisert 1982, 1990 & 1997; Vonnahme et al. 1999). This 
estrogen release from the conceptus regulates the release of pregnancy associated protein 
secretions from the uterus (Roberts et al. 1993), prostaglandin synthesis and release 
(Bazer and Thatcher 1977; Vonnahme et al. 1999), uterine blood flow (Ford et al. 1982; 
Vonnahme et al. 1999), and uterine cellular morphology (Geisert et al. 1982; Keys and 
King 1990). The mechanism by which estradiol-17β regulates endometrial secretory 
activity and the factor or factors induced by conceptus estradiol-17β to orchestrate these 
uterine changes conductive to conceptus development and survival have not been fully 
elucidated (Vonnahme et al. 1999). 
Pig conceptuses form a noninvasive, diffuse, epitheliochorial placenta (King et al. 1982; 
Keys and King 1990). During placentation the glycoproteins present within the uterine 
microvillus glycocalyx aid in the attachment of the conceptus to the uterine surface 
(Dantzer, 1985). Geisert, et al. (1998) isolated and characterized a glycoprotein 
homologous to inter-α-trypsin inhibitor heavy chain 4 (IαIH4) (Geisert et al. 1998). It is 
believed that IαIH4 and other IαI family members play a role in stabilization of 
extracellular matrix (Bost et al. 1998) where heavy chains of the IαI family members 
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contain a Von Willebrand type A domain that functions as a target for adhesion 
molecules such as integrins, collagen, and heparin (Salier et al. 1996). IαIH4 is unique in 
relation to other known IαI family members as IαIH4 contains a cleavage site for the 
serine protease kallikrein (Hashimoto et al. 1996). Tissue kallikreins are serine proteases 
(Gan et al. 2000). Some of which are active members of the kallikrein-kininogen-kinin 
system which cleaves kininogen to release the vasoactive peptide, bradykinin (Bhoola et 
al. 1992). Kinins released from kininogen are normally involved in many inflammatory-
associated effects such as prostaglandin synthesis and release, smooth muscle 
contraction, histamine release and increased blood flow (Bhoola et al. 1992) which are 
similar to the uterine alterations that occur in the pig during establishment of pregnancy 
(Stroband and Van der Lende 1990; Geisert et al. 1990). 
Previous studies have shown that the kallikrein -kininogen-kinin system to be involved 
with ovulation  and implantation in the rat (Gao et al. 1992; Valdes et al. 1996). 
Vonnahme and coworkers (1999) have demonstrated that endometrial tissue kallikrein 
enzymatic activity, protein and gene expression is present during the porcine estrous 
cycle and early pregnancy. Presence of kallikrein suggests that the kallikrein-kininogen-
kinin system is active in the pig uterus and could play a role in conceptus trophoblast 
attachment through cleavage of  IαIH4. Tissue kallikrein cleaves porcine IαIH4 into 100 
kDa and 35 kDa fragments, where the 100 kDa fragment is further cleaved into a 70 kDa 
fragment (Hashimoto et al. 1996). During conceptus trophoblastic elongation and 
attachment, a 30 kDa fragment corresponding to the C-terminal of IαIH4 has been 
detected within the uterine lumen (Geisert et al. 1995) suggesting that tissue kallikreins 
may play a role within the uterine lumen of the pig to help regulate alterations in IαIH4 
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necessary for conceptus attachment and placental development (Vonnahme et al. 1999). 
In addition, the expression of low molecular weight kininogen in the porcine uterus 
(Vonnahme et al. 2004) during early gestation further suggests that the K-K-K system is 
active in the pig.  
Although previous studies have shown tissue kallikrein gene expression in cyclic and 
pregnant gilts, it is not clear whether kallikrein gene expression is due to activation of 
prekallikrein or due to altered gene expression. Therefore, further studies are necessary to 
determine whether kallikrein gene expression is altered during the estrus cycle and early 
pregnancy or if the changes in kallikrein gene expression is due to activation of kallikrein 
activity from prekallikrein (Vonnahme et al. 1999). Unfortunately, little is known about 
the kallikrein gene family in the pig. Except for the kallikrein 4 sequence (Ryu et al. 
2002) isolated from pig dentine (genbank accession # U76256), no other porcine tissue 
kallikreins have been identified thus far. Therefore, as first step towards isolation, 
characterization and functional analysis of the porcine kallikrein gene family, a BAC 
clone-based physical map of the greater kallikrein gene region of the pig was constructed 
and was mapped to porcine chromosome 6q1.2 2 with high confidence. We have also 
initiated the sequence analysis of the whole kallikrein gene region in the pig and have 
isolated several new porcine tissue kallikreins.   
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Materials and Methods 
 
Overgo Probe Design and Labeling 
 
Overgo probes were designed for all known human kallikrein exonic sequences  
(except kallikrein 11) using publicly available sequence information. Care was taken to 
avoid interspersed repeats and low complexity DNA sequences by analyzing human 
kallikrein gene sequences using RepeatMasker (http://www.repeatmasker.org/). The 
resulting sequences were used to design overgo probes using  “Overgo Maker” available 
at http://www.genome.wustl.edu/tools/?overgo=1. Each Overgo probe generated was 40 
bp in length and contained two 24-mer oligonucleotides with an 8 bp overlap at their 3’ 
ends (Sambrook and Russel 2001). Overgo probes had a 50% GC content and were 
highly specific to kallikrein gene targets. 
Overgo probes were synthesized (Integrated DNA Technologies, Coralville, IA, 
USA) and a 10 pmol/µl stock solution was prepared. The 3’ ends of the two 
oligonucleotides were annealed by mixing the two complementary 24-mer 
oligonucleotides and heating the mixed oligonucleotides at 80ºC for 5 minutes, 
incubating at 37ºC for 10 min and placing on ice. Annealed oligonucleotides were then 
subjected to radioactive primer extension to produce a 40 bp double-stranded 
radiolabeled probe (Sambrook and Russel 2001).  
The overgo labeling reaction for radioactive primer extension contained, 1 pmol/µl 
annealed oligonucleotides, 100 µg/ml BSA, 2 µl OLB [prepared by mixing solution A, B 
and C in 1:2.5:1.5 ratio. (Solution A: 1 ml of solution O, 18 µl of β-mercaptoethanol, 5 µl 
of 100 mM  dTTP, and 5 µl of 100 mM dGTP); (Solution B: 2M HEPES pH 6.6); 
(Solution C: 3 mM Tris-Cl, 0.2 mM EDTA); (Solution O: 1.25 mM Tris-Cl, 125 mM 
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MgCl2)], 0.5 µl of 10mCi/ml [α-32P]dATP, 0.5 µl of 10mCi/ml [α-32P]dCTP and 2U 
klenow fragment (Sambrook and Russel 2001). Reaction mix was incubated at room 
temperature for 1 hour and unincorporated nucleotides were removed using Sephadex-
G50 columns (Amersham, Piscataway, NJ, USA) by centrifuging the labeling reaction in 
Sephadex- G50 columns for 2 min at 3000 rpm according to manufacture’s protocol.  
 
Southern Blotting 
 
The specificity and sensitivity of the overgo probes developed was evaluated using 
Southern blots. Briefly, porcine genomic DNA was extracted and digested with EcoR I 
and Hind III (Promega, Madison, WI, USA) by incubating at 37ºC for 6 hrs. Digest was 
electrophorized on a 0.85% agarose gel and was washed in 0.25 M HCl for 20 min, twice 
in denaturation solution (1.5 M NaCl and 0.5M NaOH) for 30 min each, twice in 
neutralization solution (1.0 M Tris pH-8, 1.5 M NaCl), and in 10X SSC for 30 min. DNA 
was transferred to a hybond® nylon membrane (Amersham, Piscataway, NJ, USA) over 
a period of 24 hrs using the downward blotting technique. After transfer, the membrane 
was UV cross-linked to immobilize the DNA.  
Membrane strips were used to evaluate the specificity and sensitivity of the overgo 
probes by hybridization. Briefly, the membranes were prewetted in 2X SSC and 
prehybridized with 10 ml of hybridization solution (1% BSA, 1 mM EDTA, 7% SDS, 0.5 
M NaPO4) for 4 hrs. After adequate prehybridization, denatured radiolabeled overgo 
probes (denatured by incubating at 90ºC for 10 min) were individually hybridized to pig 
genomic DNA containing membrane strips. The hybridization was carried out overnight 
at 60ºC.  Following hybridization overnight at 60ºC, the filters were washed in 1.5X SSC/ 
 50
0.1% SDS at 58ºC for 30 min and then in 1.0X SSC/ 0.1% SDS at 58ºC for 30 min. 
hybridization of the probes were detected by exposure of the filter to Bio-Max max 
efficiency X-ray film (Invitrogen, Carlsbad, CA, USA) for 10-12 hrs at -80ºC.           
 
Porcine BAC Library Screening 
 
High-density gridded membranes containing 6.3X coverage of porcine genome  
(Pieter de Jong; http://www.chori.org/bacpac/) were screened using protocols previously 
described by Sambrook and Russel, (2001). Briefly, the BAC filters were prewetted in 
2X SSC and prehybridized with 50 ml of hybridization solution (1% BSA, 1 mM EDTA, 
7% SDS, 0.5 M NaPO4) for 4 hrs. After prehybridization, radiolabeled overgo probes 
were pooled denatured and used for hybridization. Hybridization was carried out 
overnight at 60ºC.  Following hybridization, filters were washed in 1.5X SSC/ 0.1% SDS 
at 58ºC for 30 min followed by 1.0X SSC/ 0.1% SDS at 58ºC for 30 min. Signals were 
detected by exposure of the filter to Bio-Max max efficiency X-ray film for 10-12 hrs at  
-80ºC. Positive clones isolated by this screen were further evaluated by hybridization 
experiments using individual probes. Table 6 lists the Overgo probe sequences used for 
BAC library screening. 
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Table 6. Overgo probes used to screen the high-density porcine BAC 
library. The different kallikrkeins are given as KLK1-KLK15. The two 
complementry 24 bp long overgo probes are given as Ova & Ovb. The 
overgo probes developed for porcine KLK4 is given as Sus-Ova & Sus-Ovb.  
Probe Genbank Accession Sequence 5'-3' 
KLK1-Ova   M25629 CGCCACAACTTGTTTGACGACGAA 
KLK1-Ovb  CAAACTGGGCTGTGTTTTCGTCGT 
KLK2-Ova   M18157 TGTACACCAAGGTGGTGCATTACC 
KLK2-Ovb  TCCTTGATCCACTTCCGGTAATGC 
KLK3-Ova   M27274 TGGTGTGCTTCAAGGTATCACGTC 
KLK3-Ovb  TGGTTCACTGCCCCATGACGTGAT 
KLK4-Ova   AF113141 ACGGATTCGTCCAACTTGATGAGC 
KLK4-Ovb  TCGCTAACGACCTCATGCTCATCA 
KLK5-Ova   AF135028 CAACATCTCTGGGAAGGAATGAGG 
KLK5-Ovb  GACACTCCTTTCAGACCCTCATTC 
KLK6-Ova   AF013988 TGGATCCAGTTCGTGTATCTGCAG 
KLK6-Ovb  GAGTCTACACCAACGTCTGCAGAT 
KLK7-Ova   AF166330 CCACTTGGTGAACTTGCACACTTG 
KLK7-Ovb  CCCAGGAGTCTACACTCAAGTGTG 
KLK8-Ova   AF095743 GTCACGCAGTTGAAGAAGCATCAG 
KLK8-Ovb  GGACCACAACCATGATCTGATGCT 
KLK9-Ova   AF135026 TTGGATCCAGTCAAGGTAGTGGCA 
KLK9-Ovb  AGTCTACACCAGCGTATGCCACTA 
KLK10-Ova   NM_002776 CCACTTCCTGCATTTCAGCTTCAG 
KLK10-Ovb  CCATTCTCTGCCTGTACTGAAGCT 
KLK12-Ova   AF135025 CTGAGACGTGGCACTCGGTGCCAG 
KLK12-Ovb  AATGACTGTGCAACCGCTGGCACC 
KLK13-Ova   AF135024 ACTGGGAATAAGGAGCAGAGAAGG 
KLK13-Ovb  ACATGGTCTGCTTAGCCCTTCTCT 
KLK14-Ova   AF161221 CACTGGGTTGAAGTCTGCTCATAG 
KLK14-Ovb  CTAGTCTATAGCTCCGCTATGAGC 
KLK15-Ova   AF242195 TGCTGATGTTGGCACAATGCAACG 
KLK15-Ovb  GTGAGTCTCCCAGATACGTTGCAT 
Sus-Ova   U76256 ACACCAACCTCTGCAAATTCACGG 
Sus-Ovb   GTCGTCTGTATCCAGTCCGTGAAT 
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Individual Clone Lysis and Hybridization 
 
BAC clones isolated in the previous experiment were tested for the presence of individual 
kallikrein genes using a protocol previously described (DeSilva 1998). Clones were 
grown overnight in a 96 well plate containing 2X YT broth and 20 µg/ml of 
chloramphenicol (Fischer, Pittsburgh, PA, USA). Clones were spotted on hybond® nylon 
membrane (Amersham, Piscataway, NJ, USA) using a plate replicator and were grown 
on the membrane by placing the membrane on a plate containing 2X YT agar and 20 
µg/ml of chloramphenicol overnight. Bacterial cells were lysed by placing the filter 
colony side up on Whatman 3MM paper saturated with 10% SDS for 5 min, 0.5 M NaOH 
/ 1.5 M NaCl for 5 min, twice with 0.5 M Tris pH 8 / 1.5 M NaCl for 5 min, 2X SSC / 
0.1% SDS for 5 min, and 2X SSC for 5 min. The filters were dried and UV cross-linked 
before use. Filters were hybridized using individual overgo probes as described 
previously. 
 
Pig Genomic DNA Isolation 
 
Genomic DNA was isolated from porcine blood. Blood was collected from gilts by 
venipuncture and was collected in heparinized vaccutainer tubes. Twenty milliliters of 
chilled 2x sucrose solution (0.637 M sucrose, 20 mM Tris-base, 10 mM MgCl2.6H2O, 2% 
Triton X-100, pH 7.6) was added to 20 ml of porcine blood and centrifuged at 2500 rpm 
at 4ºC for 30 min. Resulting pellet was resuspended in 1 volume of 1X sucrose solution 
and centrifuged at 2500 rpm at 4ºC for 30 min. Pellet was resuspended in 0.25 volume of 
sucrose/proteinase K cell lysis buffer (27% sucrose, 1X SSC, 1mM EDTA, 1% SDS, 200 
µg/ml proteinase K) and incubated at 37ºC overnight. The lysate obtained was extracted 
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using 10 ml of phenol (saturated with 1 M Tris-Cl): chloroform: isoamyl alcohol 
(25:24:1). The resulting DNA was precipitated in the aqueous phase with 1 volume of 
isopropyl alcohol. DNA was spooled on a pasture pipette and was washed with 70% 
ethanol, air dried and resuspended in water (Sambrook and Russel 2001). 
       
BAC DNA Isolation 
 
Individual BAC clones were inoculated into 2 ml of 2X YT broth containing 20 µg/ml of 
chloramphenicol (Fischer, Pittsburgh, PA, USA) and incubated in a shaking incubator 
(225 rpm) at 370C for 4-5 hrs. Following incubation, the culture was added to 50 ml of 
2X YT broth containing 20 µg/ml chloramphenicol (Fischer, Pittsburgh, PA, USA) and 
was incubated in a shaking incubator (225 rpm) at 37ºC for 16-22 hrs. The total 52 ml 
volume was used to isolate BAC DNA (Sambrook and Russel 2001). Briefly, the 
overnight cultures were centrifuged at 4500 rpm at 4ºC for 30 min. The resulting pellet 
was resuspended in 0.1X volume of chilled GET buffer (50 mM glucose, 25 mM Tris-
HCl, pH 8.0, and 10 mM EDTA, pH 8) and 60 µl of 20 mg/ml RNAseA. Five milileters 
of fresh solution I (0.2N NaOH, 1% SDS), and 5 ml of 3M KOAc pH 5.5 was added to 
the lysate which was then incubated on ice for 10 min, and was centrifuged at 15,000 rpm 
at 4ºC for 30 min. Isopropanol (0.67 volume) was added to the supernatant and incubated 
at room temperature for 15 min and centrifuged at 15,000 rpm at room temperature for 30 
min. DNA precipitated was washed with 70% ethanol, air dried and resuspended in 
water. 
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Kallikrein 4 PCR assay 
 
Porcine kallikrein 4 forward (5’ CTGGGTCTGCACAATCTTGA 3’) and reverse (5’ 
AGACAGCGACACCGATTCTT 3’) primers were developed (within an exon) for PCR 
amplification from the known porcine kallikrein 4 sequence (GenBank accession # 
U76256) using Primer3 software (Rozen and Skaletsky 2000). The PCR product size was 
147 bp.  
The PCR reactions were performed in a MJ Dyad thermal cycler (MJ Research Inc., 
Waltham, MA, USA). 20 µl reaction mix contained 1 µl  DNA, 1X PCR buffer (Applied 
Biosystems, Foster City, CA, USA) 1.5 mM MgCl2, 25 pmol of each primer, 200 µM 
dNTPs and 3 U Taq DNA Polymerase (Promega, Madison, WI, USA). Cycling 
conditions were: one cycle of 1 min at 95ºC, 30 sec at 60ºC, 15 sec at 72ºC followed by 
34 additional cycles of 30 sec at 94ºC, 30 sec at 62ºC, 15 sec at 72ºC and a final 
extension of 3 min at 720C. The resulting PCR products were electrophorized in a 1.5% 
agarose gel and stained with 5 µl of ethidium bromide (10 mg/ml). 
 
BAC End Isolation 
 
The end fragments of the BAC clones were isolated by Vectorette PCR end rescue 
approach (Thomas, J.W.  Personal Communication). Briefly, 5 µg of BAC DNA was 
digested with either Hae III or Pvu II (Promega, Madison, WI, USA) by incubating at 
37ºC for 2 hrs and heating to 65ºC for 30 min. The digestion contained 5 µg of DNA, 1X 
buffer, 4U restriction enzyme). A vectorette duplex linker (2 µM of BPB I and BPH II 
oligos heated to 680C for 15 min and slowly cooled to room temperature over 30 min to 
form the duplex linker) was ligated to the digested DNA by incubating at 37ºC for 2 hrs. 
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The ligation reaction contained 10 µl of restriction digest, 1X ligase buffer, 2U T4 ligase 
(Invitrogen, Carlsbad, CA, USA), and 7 nM/ µl vectorette duplex linker.  
The ligated product was PCR amplified using T7BACF/ SP6 BACR primers and 224 
universal primer. PCRs were performed in a MJ Dyad thermal cycler.  The 20 µl reaction 
mix contained 1 µl  DNA, 1X PCR buffer (Applied Biosystems, Foster City, CA, USA) 
1.5 mM MgCl2, 25 pmol of each primer, 200 µM dNTPs and 3 U Taq DNA Polymerase 
(Promega, Madison, WI, USA). Cycling conditions were one cycle of 1 min at 95ºC, 30 
sec at 55ºC, 1 min at 72 ºC followed by 34 additional cycles of 30 sec at 94ºC, 30 sec at 
55ºC, 1 min at 72ºC and a final extension of 3 min at 72ºC. Single-copy BAC ends 
obtained were TA cloned and sequenced.  
The primer and vectorette oligonucleotide linker sequences are: 
BPB I:   5’ CAAGAAGAGGACGCTGTCTGTCGAAGGTAAGGAACGGACGAGAGAAGGGAGAG 3’ 
BPH II:  5’ CTCTCCCTTCTCGAATCGTAACCGTTCGTACGAGAATCGCTGTCCTCTCCTTG 3’ 
224:    5’ CGAATCGTAACCGTTCGTACGAGAATCGCT 3’ 
T7BACF:  5’ CCGCTAATACGACTCACTATAGGG 3’ 
SP6BACR: 5’ GTCGACATTTAGGTGACACTATAG 3’ 
 
TA Cloning 
 
The BAC ends isolated by vectorette PCR end rescue approach were TA cloned using 
TOPO® TA cloning kit according to manufacturer’s protocol (Invitrogen, Carlsbad, CA, 
USA). Briefly, fresh PCR products were ligated to vector pCR®2.1-TOPO® by incubating 
at room temperature for 20 min. The 6 µl ligation mix contained, 2 µl of fresh PCR 
product, 1 µl of pCR®2.1-TOPO® vector, 1 µl of salt solution, and 2 µl of water. The 
ligated PCR product (2 µl) was added to 25 µl vial of chemically competent cells and 
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incubated on ice for 30 min. The cells were heat-shocked for 30 sec at 42ºC without 
shaking. SOC medium (250 µl) was added to the heat-shocked cells and were incubated 
at 37ºC for 1 h in a shaking incubator at 225 rpm. Each transformation was spreaded on 
YT plates containing X-gal (40 mg/ml) and ampicillin (50 µg/ml). The plates were 
incubated at 37ºC overnight. Positive white clones were selected and further analyzed 
using cell burst PCR. 
 
“Cell Burst” PCR      
 
A small sample of a bacterial colony was collected on a toothpick, mixed in 30 µl of 
water and heated at 95ºC for 5 min to lyse cells. One microliter of this cell lysis was used 
for PCR using specific BAC end primers to select positive clones.  
 
BAC End Sequencing 
 
The PCR products generated through vectorette-PCR were treated with shrimp alkaline 
phosphatase (1u µl-1) and Exonuclease III (10u µl-1) at a volume equaling 5% of the PCR 
product and was incubated at 37°C for 30 min followed by 80°C for 10 min. Sequencing 
reactions were performed in a 10 µl reaction mix containing 2 µl PCR product, 1 mM 
sequencing primer, 2 µl of BigDye dye terminator mix (Applied Biosystems, Foster City, 
CA, USA) and 1µl buffer (400 mM Tris, pH 9, 10 mM MgCl2). Cycling conditions were: 
60 cycles of 30 sec at 95°C, 20 sec at 50°C, and 4 min at 60°C. Sequencing reactions 
were cleaned using DTR Gel Filtration columns (Edge Biosystems, Gaithersburg, MD, 
USA) and analyzed on an ABI 3700 DNA analyzer (Applied Biosystems, Foster City, 
CA, USA). 
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Development of a BAC Insert End-Specific PCR Assay 
 
Sequences derived from BAC insert ends were analyzed, and BAC vector sequences 
were removed manually. The resulting sequences were analyzed for human and other 
mammalian repeats using RepeatMasker web server (http://www.repeatmasker.org/cgi-
bin/WEBRepeatMasker), and PCR primers were designed from non-repetitive sequences 
using Primer 3 software  (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi/) 
(Rozen and Skaletsky, 2000). Primer sequences developed are listed in Table 7. 
The PCR reactions were performed in a MJ Dyad thermal cycler (MJ Research Inc., 
Waltham, MA, USA). 20 µl reaction mix contained 1 µl  DNA, 1X PCR buffer (Applied 
Biosystems, Foster City, CA, USA) 1.5 mM MgCl2, 25 pmol of each primer, 200 µM 
dNTPs and 3 U Taq DNA Polymerase (Promega, Madison, WI, USA). Cycling 
conditions were: one cycle of 1 min at 95ºC, 30 sec at 60ºC, 15 sec at 72ºC followed by 
34 additional cycles of 30 sec at 94ºC, 30 sec at 62ºC, 15 sec at 72ºC and a final 
extension of 3 min at 72ºC. 
 
BAC Fingerprinting Analysis 
 
The positive BAC clones isolated through BAC library screening were subjected to 
restriction enzyme digest based fingerprinting analysis as described previously by Marra 
et al. (1997). Briefly, purified BAC DNA was digested with Hind III and electrophorized 
in a 1% agarose gel at 45V for 16 hrs, and stained with SYBR green (Applied 
Biosystems, Foster City, CA, USA). The gel was imaged using a molecular Dynamics 
Fluorimager (Amersham, Piscataway, NJ, USA). The resulting image was then 
transferred to a UNIX workstation for band calling and contig assembly. Restriction 
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fragment bands were identified using the program Image 3.3 and contigs were 
constructed using FPC (Finger Printed Contigs). 
Table 7.  Primer sequences used for BAC end-specific PCR assay. 
Primer Sequence 5'-3' Length (bp) 
PCR 
Product 
Size (bp) 
Tm Used 
329R-F    TTTCATTGCTTTTGCCTCCT 20 213 62ºC 
329R-R    GAACCCAAGGCTGGTGACT 19  62ºC 
069F-F    CCCAAGGTCATGGTCTGATT 20 103 62ºC 
069F-R    GGAACGTGACATTGCAGGTA 20  62ºC 
117F-F    CCTCCTTCTTAGCTGGGTTG 20 79 62ºC 
117F-R    GAAACTTGCTCGAGCCTCAT 20  62ºC 
117R-F    ACGTGCGGTCCTAAAAAGAC 20 85 60ºC 
117R-R    CCCCCAATAAACAAAAGTCA 20  60ºC 
370F-F    TTACTGCTGAGCCACACTGG 20 93 62ºC 
370F-R    CATGAAGCCATCACCACAAT 20  62ºC 
329F-F    GAACGTACGCCAGGCACT 18 109 62ºC 
329F-R    CCGTACTGGAGAAGCCAGAC 20  62ºC 
370R-R    CCTGGGGCTCTATCCTCTCT 20 150 62ºC 
370R-F    GGCCTTTCCTGTCATCCAG 18  62ºC 
 
 
Radiation Hybrid (RH) mapping 
 
Radiation hybrid mapping was performed using INRA-Minnesota 7000 rads radiation 
hybrid panel (IMpRH), which consisted 118 hamster-porcine hybrid cell lines (Hawken 
et al. 1999; Yerle et al. 1998). The previously described kallikrein 4 primers were used to 
score the porcine RH map.  
Each of the 118 clones in the RH panel was used as a template in PCR. The entire RH 
panel was scored twice by PCR twice for the kallikrein 4 primer pair. The PCR reactions 
were performed in a MJ Dyad thermal cycler. A 20µl reaction mix contained 1µl  DNA, 
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1X PCR buffer (Applied Biosystems, Foster City, CA, USA) 1.5 mM MgCl2, 25 pmol of 
each primer, 200 µM dNTPs and 3 U Taq DNA Polymerase (Promega, Madison, WI, 
USA). Cycling conditions were one cycle of 1 min at 95ºC, 30 sec at 62ºC, 15 sec at 72ºC 
followed by 34 additional cycles of 30 sec at 94ºC, 30sec at 62ºC, 15 sec at 72ºC and a 
final extension of 3 min at 72ºC according to the INRA protocols 
(http://www.toulouse.inra.fr/lgc/lgc.htm). PCR products were separated on 2% agarose 
gels with 500 ng/ml of ethidium bromide. No PCR product was obtained for the rodent 
genomic DNA. Data analysis was performed using software available at IMpRH database 
(http://imprh.toulouse.inra.fr) for chromosome assignment. Briefly, the radiation hybrid 
map is constructed using RHMAP 3.0 package. A multipoint analysis and ordering of the 
markers is performed on the positive clones submitted using the various ordering options 
of the RHAMXLIK program of RHMAP 3.0 (Hawken et al. 1999).   
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Results 
No pre-existing mapping information was available for the pig kallikrein region. Except 
for KLK4 (isolated from pig dentine, Genbank accession # U76256) and porcine plasma 
kallikrein (Genbank accession # NM_214074) no other porcine kallikreins had been 
identified thus far. As a first step towards isolation, characterization and functional 
analysis of the porcine kallikrein gene family, overgo probes were developed for all 
known human kallikrein exonic sequences except kallikrein 11, using sequence 
information available at NCBI. Overgo probes were used to screen CHORI-242 porcine 
BAC library. Library screening identified 8 positive clones that contained putative 
kallikrein gene fragments (clones: 003F18, 069G11, 117C13, 266E15, 329F12, 338F22, 
366F08, and 370C15) while clone 051O23 was selected in random as a negative control. 
Figure 4 depicts a representative BAC filter which contains 2 positive clones. The 
resulting clones selected were further confirmed by PCR using primers developed for pig 
kallikrein 4, which confirmed that out of the 8 positive clones selected, seven to have 
porcine kallikrein 4. (Figure 5). Insert ends of the selected  BAC clones were isolated 
using vectorette PCR end rescue approach (Figure 6) and sequenced. Sequence Tagged 
Sites (STS) were developed from clone insert ends and were used to assemble the BAC 
clones into a contig (Figure 7). Hybridization experiments were carried out on individual 
BAC clones using individual overgo probes to identify the number of kallikreins on each 
clone (Figure 8). Subsequent sequence analysis of BAC insert ends and overgo-based 
hybridization experiments with human kallikreins resulted in a BAC clone-based physical 
map of the porcine greater kallikrein region (see Figure 9). The assembled contig of the 
pig kallikrein region containing 8 BAC clones provides ordering information for 12 
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STSs. Of the 12 STSs, seven correspond to BAC insert ends, five new tissue kallikrein 
genes in the pig and one to the previously identified pig kallikrein 4 gene.   
To further confirm the relationship between individual clones in the contig and to identify 
a minimal tiling set of clones for sequencing the greater kallikrein region of the pig, all 8 
BAC clones that represent the kallikrein region in the pig were subjected to restriction 
enzyme-based fingerprint analysis using a method developed at the Washington 
University Genome Sequencing Center (Marra et al. 1997). The resulting data were 
analyzed by FPC (Soderlund et al. 1997), which yielded one contig. The relative order 
and orientation of the FPC-generated, fingerprint-based contig and the PCR assay and 
hybridization based contig were identical. Based on the length of all non-redundant 
restriction fragments the total length of the contig is ~375 kb.  
Based on the Human–Pig comparative map (Fronicke et al. 1996) we assumed that the 
pig kallikrein region may map to porcine chromosome 6. A PCR assay was developed for 
porcine kallikrein 4 (KLK4) and a pig-hamster radiation hybrid (RH) panel was scored 
twice to map the kallikrein region in the porcine genome. A representative PCR panel is 
shown in figure 10. PCR amplification can be seen in hybrid clones that contain 
kallikrein DNA. The results (Table 8) revealed that KLK4 marker was linked to first-
generation markers of Sus-scrofa Chromosome 6 (SSC6) (Hawken et al. 1999) with LOD 
scores of greater than 7 (Table 9) by two point analysis confirming that the pig kallikrein 
region is clustered within pig chromosome 6q12-q21 (see Figure 11). 
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Figure 4 
 
A representative BAC filter (#8) containing two positive clones (circled in red). The BAC 
filter only 22 X 22 cm in size contains 18,432 individual clones which are gridded in 
duplicate in specific patters to prevent calling of false positives and to help identify the 
clone address. 
The 6.3X deep porcine BAC library was screened using overgo probes (table 4). The 
overgo probes were developed using human tissue kallikrein exonic sequences.  
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Figure 5 
 
Ethidium bromide stained gel confirming that the positive BAC clones isolated to have 
porcine tissue kallikreins. DNA was extracted from the BAC clones selected and was 
PCR amplified using primers specific to pig kallikrein 4. PCR products were separated in 
a 2% agarose gel in TBE for 30 min at 90V. Name of each clone are given at the top of 
the figure. BAC clones identified from screening high-density BAC filters were tested by 
PCR for the presence of porcine kallikrein 4. kallikrein 4 was detected in clones 003F18, 
069G11, 117C13, 266E15, 329F12, 338F22, 366F08, and absent in 370C15 and the 
negative control 051O23.  
gDNA= genomic DNA.   
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Figure 6 
 
Ethidium bromide statined gel depicting BAC clone ends isolated by vectorette PCR end 
rescue approach. BAC DNA was digested with Hae III or Pvu II and a vectorette duplex 
linker (Bubble) was ligated and PCR amplified using a vector based primer and universal 
primer developed for the ds DNA linker. PCR products were separated in a 1.2% agarose 
gel. Single-copy BAC ends obtained were TA cloned and sequenced. Name of each clone 
is given at the top of the figure. The sizes of the BAC ends isolated ranged from ~400 bp 
to ~1.2 kb.    
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Figure 7 
 
PCR panel of the BAC end specific PCR assay. Sequence Tagged Sites (STS) were 
developed from BAC clone insert end sequences and PCR was performed on each BAC 
clone using all STS to assemble the BAC clones in to a contig. PCR products were 
separated in a 2% agarose gel in TBE for 30 min at 90V. The name of each BAC clone in 
the contig is given on the top of the panel, and the name of each BAC insert end specific 
STS is given in the vertical axis. “F” and “R” are arbitrarily assigned letters. 
The negative control (51O23) did not show any amplification. The clone from which the 
STS was developed and genomic DNA was used as positive controls.     
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Figure 8 
Hybridization experiments carried out on each BAC clone using individual overgo probes 
to identify the number of kallikreins on each clone (1-370C15, 2-366F08, 3-329F12, 4-
306H02, 5-266E15, 6-256O23, 7-117C13, 8-069G11). The BAC clones were grown on a 
hybond nylon filter, lysed and were hybridized with individual overgo probes. The filter 
strips were washed and signals were detected by exposing the filter to Bio-Max max 
efficiency X-ray film for 10-12 hrs at –800C. Clones 003F18 and 338F22 were not tested 
as these two clones were identified in the second screening. 
Signals were detected for KLK1, KLK4, KLK6, KLK9, KLK12 and KLK15. The 
presence of KLK2, KLK3, KLK5, KLK7, KLK8, KLK10, KLK13 and KLK14 could not 
be detected with the overgo probes we used. This may be because we developed probes 
from human kallikrein sequences and screened across species. Therefore the overgo 
probes that we designed for some of the kallikreins were not homologous to screen across 
species.  
The negative clone 51O23 did not hybridize to any probe. 
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Figure 9 
 
BAC clone based physical map of the pig kallikrein region based on sequence analysis of 
BAC insert ends and overgo-based hybridization experiments with human kallikreins. 
Clones are depicted as horizontal lines.  STSs are listed vertically along the top, with 
those depicted in red derived from clone insert ends, those in blue are new porcine tissue  
kallikrein genes. All STSs are not to scale. The size of each BAC clone is given in 
parenthesis next to the clone name. Unfilled squares on clones 003F18 and 338F22 show 
untested STSs. 
Based on the physical map generated, clone 69G11 was selected to have all porcine tissue 
kallikreins genes. 
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Figure 10   
 
A representative PCR panel showing results obtained by scoring the Pig-hamster 
radiation hybrid (RH) panel using porcine KLK4 primers. A PCR assay was developed 
for porcine kallikrein 4 (KLK4) and was used to analyze the pig-hamster radiation hybrid 
(RH) panel to map the kallikrein region in the pig. Each clone was scored twice using 
PCR. PCR amplification can be seen in hybrid clones that contain kallikrein DNA. The 
positive clones for both rounds of PCR (Table 6) were further analyzed using mapping 
software available at IMpRH database (http://imprh.toulouse.inra.fr) for chromosome 
assignment.  
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Table 8. Radiation Hybrid Mapping results. Each clone was scored twice using 
primers developed for porcine KLK4. The clones that were positive for both 
rounds of screening is shown with a “+” symbol.  
PLATE WELL IMpRH # Result PLATE WELL IMpRH # Result PLATE WELL IMpRH # Result
1 A1 L1   1 D7 L43  1 H1 L84 + 
1 A2 L2  1 D8 L44  1 H2 L85  
1 A3 L3  1 D9 L45  1 H3 L86  
1 A4 L4  1 D10 L46  1 H4 L87 + 
1 A5 L5  1 D11 L47  1 H5 L88  
1 A6 L6  1 D12 L48 + 1 H6 L89  
1 A7 L7  1 E1 L49  1 H7 L90  
1 A8 L8  1 E2 L50 + 1 H8 L91  
1 A9 L9  1 E3 L51  1 H9 L92  
1 A10 L10  1 E4 L52  1 H10 L93  
1 A11 L11  1 E5 L53  1 H11 L94  
1 A12 L12 + 1 E6 L54  1 H12 L95  
1 B1 L13  1 E7 L55 + 2 A1 L96  
1 B2 L14  1 E8 L56  2 A2 L97  
1 B3 L15  1 E9 L57  2 A3 L98 + 
1 B4 L16 + 1 E10 L58  2 A4 L99  
1 B5 L17  1 E11 L59  2 A5 F100  
1 B6 L18  1 E12 L60  2 A6 F101 + 
1 B7 L19  1 F1 L61  2 A7 F102  
1 B8 L20  1 F2 L62  2 A8 F103 + 
1 B9 L21  1 F3 L63  2 A9 F104  
1 B10 L22 + 1 F4 L64  2 A10 F105  
1 B11 L23  1 F5 L65  2 A11 F106  
1 B12 L24  1 F6 L66  2 A12 F107 + 
1 C1 L25  1 F7 L67  2 B1 F108  
1 C2 L26  1 F8 L68  2 B2 F109  
1 C3 L27  1 F9 L69  2 B3 F110  
1 C4 L28  1 F10 L70  2 B4 F111  
1 C5 L29  1 F11 L71 + 2 B5 F112 + 
1 C6 L30  1 F12 L72  2 B6 F113 + 
1 C7 L31 + 1 G1 L73  2 B7 F114 + 
1 C8 L32  1 G2 L74  2 B8 F115 + 
1 C9 L33 + 1 G3 L75  2 B9 F116  
1 C10 L34  1 G4 L76  2 B10 F117  
1 C11 L35 + 1 G5 L77  2 B11 F118 + 
1 C12 L36  1 G6 L78  2 B12 Positive + 
1 D1 L37  1 G7 L79  2 C1 Negative  
1 D2 L38  1 G8 L80 + 2 C2 Parent + 
1 D3 L39  1 G9 L81  2 C3 Parent + 
1 D4 L40  1 G10 Positive + 2 C4 Parent + 
1 D5 L41  1 G11 L82  2 C5 Parent + 
1 D6 L42    1 G12 L83    2 C6 Parent + 
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Table 9. The results obtained from Radiation Hybrid panel mapping 
software available at IMpRH database (http://imprh.toulouse.inra.fr). 
The results suggests that the porcine tissue kallikrein gene region 
shows high linkage to several markers on porcine chromosome 6 with LOD 
scores of 7 and higher.   
   
Order  Chromosome  Marker 
Retention 
fraction 
Distance 
(ray) 
LOD 
Score 
1 6 S0333 22 0.24 11.61 
2 6 S0300 20 0.22 11.89 
3 6 SW782 16 0.28 10.18 
4 6 S0220 20 0.33 9.37 
5 6 SSC8E02 17 0.40 7.89 
6 6 SW133 19 0.43 7.29 
7 6 SE1129 25 0.45 7.06 
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Figure 11 
 
Localization of the porcine kallikrein region to chromosome 6q1.2. KLK4 marker is 
linked to first-generation markers of Sus-scrofa Chromosome 6 (SSC6) (Hawken et al.  
1999) with LOD scores of greater than 7 by two point analysis confirming that the pig 
kallikrein region is clustered within pig chromosome 6q1.2. The Radiation Hybrid (RH) 
map is compared with Suc-scrofa chromosome 6 (SSC6) Cytogenetic map. The kallikrein 
region is circled in red. 
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Discussion 
No pre-existing physical mapping data was available for the pig kallikrein gene region, 
and except for kallikrein 4 and porcine plasma kallikrein no other porcine kallikreins had 
been identified thus far. 
The deduced physical map of the pig kallikrein region has an estimated length of 375 kb 
which is covered by the two clones 003F18 and 338F22 (Figure 8). This is comparable to 
the human kallikrein region which is estimated to be 300 kb (Yousef and Diamandis 
2001). Based on the physical map and repeated hybridization studies, we have identified 
clone 069G11 (Figure 8) to contain all the kallikrein genes identified by us so far. 
Systematic and complete sequence analysis of this clone is underway. This clone is in the 
2nd phase of sequencing; based on the sequence information available clone 069G11 has 
13 kallikrein genes (KLK1, KLK4, KLK5, KLK6, KLK7, KLK8, KLK9, KLK10, 
KLK11, KLK12, KLK13, KLK14, and KLK15) among which 12 are new tissue 
kallikreins in the pig.  
The Radiation Hybrid mapping information indicates that kallikrein gene region has 
conserved synteny between human chromosome 19 (HSA19) and porcine chromosome 6 
(SSC 6), and is consistent with the comparative mapping results obtained by bi-
directional chromosome painting (Goureau et al. 1996). We have so far used only one 
marker to map the kallikrein gene region in the RH panel resulting in fairly low 
resolution. We are in the process of adding more kallikrein markers to the panel as 
sequencing results become available. 
The physical map generated in this study would be an invaluable resource in further 
understanding of the role of kallikreins in the pig.  Novel porcine tissue kallikrein genes 
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identified will help us to evaluate the expression of tissue kallikreins in the porcine 
endometrium and conceptus during the estrus cycle and pregnancy to help us better 
understand the role of tissue kallikreins in placental development and embryonic survival 
throughout gestation in the pig.  
The tissue kallikrein loci has been extensively investigated in the human, rat and the 
mouse, which has revealed surprising differences in the number of classical glandular 
kallikrein genes, where the human has 3 and the mouse has 25, 14 of which are functional 
and 12 in the rat (Olsson et al. 2004). But, the most striking difference is the size of the 
region between KLK1 and KLK15, which is only 1.5 kb in humans, but is 290 kb in the 
mouse and contains 23 classical glandular kallikrein genes, suggesting that the rodent 
kallikreins have evolved after the human rodent split. Also the phylogenetic analysis of 
human, mouse and rat classical kallikreins revealed that KLK1 segregated according to 
species, suggesting that the duplications of KLK1 in the mouse and the rat occurred after 
the separation of species.  
The kallikrein gene family is unique from most other gene families, as in most other gene 
families the members are spread out throughout the genome, but kallikreins have always 
been found as cluster in a single chromosome. Gene family expansion is a fundamental 
process in the evolution of species. On average each gene is thought to be duplicated 
once every 100 million years, but the half life of a duplicated gene is only 4 million years 
because of the high rate of silencing (Olsson et al. 2004). “Independent duplication of the 
same gene has been shown to have evolutionary instability and usually move to the 
telomere region of different chromosomes, therefore the duplicated gene segments tend to 
be localized in pericentromeric or subtelomeric regions” (Olsson et al. 2004). However, 
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that is not the case with the tissue kallikreins as kallikrein genes were formed by tandem 
duplications and are located in a single chromosomal region. (Olsson et al. 2004).  
Therefore, the kallikrein gene family is a very interesting gene family that has evolved 
recently, but what evolutionary pressure keeps the kallikrein family clustered together is 
still unknown. It is believed that among the human kallikreins KLK4-KLK15 are single 
copy genes while the classical glandular kallikreins KLK1 and KLK2 display varying 
number of copies among species. Therefore, the mapping and sequencing data generated 
for the porcine greater kallikrein gene region should provide insight into the evolutionary 
origins of this structurally complex genomic region. 
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Introduction 
During early pregnancy in the pig, the conceptus undergoes a rapid trophoblastic 
elongation from a 10 mm sphere to a long filamentous thread-like structure (Geisert et al. 
1982a,b), and initiates attachment to the uterine epithelium on day 12 of pregnancy 
(Stroband et al. 1990; Geisert et al. 1997). During attachment of the conceptus to the 
uterine epithelium a localized increase in transcapillary transport (Keys et al. 1998) and 
uterine blood flow occurs (Ford et al. 1982) concurrently with the establishment of 
pregnancy in the pig (Bazer et al. 1982; Geisert et al. 1997).  
Many of the endometrial responses that occur during conceptus development resembles 
the acute-phase responses induced during tissue inflammation (Sailer et al. 1996; Geisert 
et al. 1997). In the pig, tissue kallikrein enzymatic activity, protein and gene expression 
has been detected during the estrous cycle and early conceptus development (Vonnahme 
et al. 1999; Geisert et al. 2001), suggesting that the kallikrein-kininogen-kinin system is 
active in the pig.  
Kallikreins have been implicated to code for proteins that activate a wide range of 
substrates and growth factors (Chan et al. 1999), suggesting that kallikreins are involved 
in many integral processes of early embryonic development such as regulation of local 
blood flow, angiogenesis, tissue invasion, and mitogenesis (Bhoola et al. 1992). In the 
rat, the kallikrein-kininogen-kinin system is activated in the ovary during ovulation 
(Brann et al. 1995). In the mouse 5 tissue kallikrein genes are implicated to play a major 
role in uterine physiological functions and during embryo implantation (Valdes et al. 
1996; Corthorn et al. 1997; Chan et al. 1999). The detection of kallikrein enzymatic 
activity and gene expression in the porcine uterine lumen (Vonnahme et al. 1999), as well 
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as the detection of the substrate of kallikrein, low molecular weight (LMW) kininogen, 
suggests the presence of an active kallikrein-kininogen-kinin system in the porcine uterus 
during early pregnancy.  
A clear temporal association between porcine conceptus estrogen release and an increase 
in uterine blood flow has been detected (Ford. 1995). The bradykinins released through 
proteolytic cleavage of LMW kininogen during early embryonic development could be 
involved in the increase of uterine blood flow, vascular permeability, prostaglandin 
release, and changes to uterine tone (Keys et al. 1990; Ford. 1995; Allen et al. 2002). 
Recent studies have shown that uterine tissue kallikrein is involved in cleavage of 
insulin-like growth factor binding proteins on day 12 in cyclic and pregnant gilts (Geisert 
et al. 2001), suggesting that several kallikreins may be present during early embryonic 
development in the pig. It is possible that several uterine tissue kallikreins may be 
involved with extracellular matrix remodeling, insulin-like growth factor binding protein 
degradation, and bradykinin release during early embryonic development in the pig 
(Geisert et al. 1998 & 2001).    
Therefore, as a first step towards understanding the tissue expression of porcine tissue 
kallikreins during reproductive events, and their role in placental development and 
embryonic survival in the pig, we have isolated two novel porcine kallikrein genes using 
RT-PCR and conserved sequence information from orthologous human kallikrein genes 
and have carried out quantitative real-time PCR based, expression analysis to evaluate the 
expression of tissue kallikrein 1, 4 and 14 in the porcine endometrium and conceptus 
during the estrus cycle and early embryonic development.   
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Materials and Methods 
Sample collection  
Cyclic, crossbred gilts of similar age (8-10 mo) and weight (100-130 kg) were checked 
twice daily for the onset of estrus behavior by intact boars. Onset of estrus was 
considered day 0 of the estrus cycle. Gilts assigned for mating were bred naturally with 
fertile boars 12h after the onset of estrus and again 12 hrs later. Cyclic gilts (n=20) were 
hysterectomized on either day 0, 5, 10, 12, 15 or 18 of the estrous cycle, whereas 
pregnant gilts (n=16) were hysterectomized on either day 10, 12, 15 or 18 as previously 
described by Gries et al. (1989). Following initial induction of anesthesia with a 1.5 ml 
i.m. administration of a cocktail consisting of 2.5 ml Rompum (xylazine; 100 mg/ml; 
Inc., Shawnee Mission, KS) and 2.5 ml Vetamine (ketamine HCl; 100 mg/ml ; 
Mallickrodt Veterinary, Mundelein, IL) in 500 mg of Telazol (tiletamine HCl and 
zolazepam HCl; Fort, Dodge, Syracuse, NE). Anesthesia was maintained with a closed 
circuit system of halothane (Halocarbon Laboratories, Riveredge, NJ) and oxygen (1.0 
L/min). After exposure by midventral laparotomy, the uterine horns and embryos were 
surgically removed. All animal procedures were in accordance with the International 
Guiding Principles for biomedical Research Involving Animals as promulgated by the 
Society for the Study of Reproduction and were approved by the Institutional Animal 
Care and Use Committee.  
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Evaluation of kallikrein 4 (KLK4) Gene Expression 
RNA Extraction from Endometrium tissue(TRIzol method)  
4 ml of TRIzol™ (Invitrogen, Carlsbad, CA, USA) was added to 1 g of tissue and was 
homogenized using a tissuemizer. This was incubated at room temperature for 5 min. 
Chloroform (1 ml) was added to the sample and incubated at room temperature for 3 min. 
After incubation the sample was centrifuged at 4ºC for 30 min at 7000 rpm. The aqueous 
phase was transferred into a fresh tube, 2.5 ml of isopropyl alcohol was added, plased in a 
-80ºC freezer for 20 min and centrifuged at 4ºC for 30 min at 12,000 rpm. Supernatant 
was discarded and the pellet was washed with 3 ml of 75 % ethanol, ethanol was 
removed and the pellet was air-dried for 5 min and resulting pellet was resuspended in 
500 µl of DEPC treated water. This RNA sample was subjected to phenol chloroform 
extraction. Briefly, phenol (saturated with 1 M Tris-Cl ): chloroform: isoamyl alcohol 
(pH 5.2) 25:24:1 was added at 1:1 ratio to the total RNA and mixed well. Following 
mixing the sample was centrifuged at 14,000 rpm for 5 min. The supernatant was 
collected to a fresh tube and 2.5 volumes of 98 % ethanol and 0.1 volume of sodium 
acetate was added, and placed in a -80ºC freezer for 30 min. The resulting RNA was 
precipitated by centrifuging at 4ºC for 30 min at 14,000 rpm. Pellet obtained was washed 
with 70 % ethanol and resuspended in 100 µl of DEPC treated water. The OD of the 
RNA samples were measured and 5 µg of RNA was run on a 1.25 % denaturation gel . 
 
RNA Extraction from Conceptus tissue (RNAWIZ™) 
Ten volumes of RNAWIZ™ (Ambion, Austin, TX, USA) was added to 1 volume of 
conceptus tissue which was vortexed until the tissue was completely homogenized. This 
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solution was incubated at room temperature for 5 min, 0.2X starting volume of 
chloroform was added to the homogenate, vortexed for ~20 sec and then incubated at 
room temperature for 10 min. After incubation the sample was centrifuged at 4ºC for 30 
min at 15,000 rpm. The aqueous phase was transferred into a fresh tube and 0.5X Starting 
volume of RNase-free water was added and mixed well. To this solution 1X Starting 
volume of isopropanol was added and was incubated at -80ºC for 30 min and was 
centrifuged at 4ºC for 15 min at 15,000 rpm. The supernatant was discarded and the pellet 
was washed with 3 ml of 75 % ethanol. The ethanol was removed and the pellet was air-
dried for 5 min. The resulting pellet was resuspended in 50 µl of DEPC treated water.  
 
DNase Treatment 
1 µl of 10X DNase I reaction buffer and 2 µl of Amp Grade DNase I (1U/µl) (Invitrogen, 
Carlsbad, CA, USA) was added to 2 µg of total RNA. The volume was brought up to 10 
µl by adding DEPC-treated water and was incubated at room temperature for 15 min. 1 µl 
of 25 mM EDTA was added to this reaction mix and was heated to 65ºC for 10 min to 
inactivate the DNase. 
 
cDNA Synthesis 
A thin walled PCR tube containing 5 µg of total RNA, 500 ng oligo dT, 750 µM dNTP 
mix was heated at 65ºC for 5 min and quickly chilled on ice. To this reaction mix, 4 µl of 
5X first strand buffer (Invitrogen, Carlsbad, CA, USA), 2 µl of 0.1 M DTT and 40 U 
RnaseOUT (Invitrogen, Carlsbad, CA, USA) was added and incubated at 42ºC for 2 min. 
200 U of SUPERSCRIPT II reverse transcriptase (Invitrogen, Carlsbad, CA, USA) was 
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added and the resulting reaction mix was incubated at 42ºC for 50 min and was heated to 
70ºC for 15 min.       
 
PCR Amplification 
Forward (5’ GTGGCTTCTGAGGAGGTCTG 3’) and reverse (5’ GCCTGGATGGTCGTCTGTAT 
3’) primers were developed (spanning an intron) for PCR amplification using know 
porcine kallikrein 4 sequence (GenBank accession # U76256) using Primer3 software 
(Rozen and Skaletsky 2000). The product size was 245 bp. 
The KLK4 primer set developed was optimized and used to evaluate gene expression in 
pregnant (d10, d12, d15 and d18) and cyclic (d0, d5, d10, d12, d15, and d18) 
endometrium using RT-PCR. Gene expression of KLK4 was also evaluated in conceptus 
tissue (d12, d14, and d16) using RT-PCR. The PCR reactions were performed in a MJ 
Dyad thermal cycler (MJ Research Inc., Waltham, MA, USA). 20 µl reaction mix 
contained 1 µl  cDNA, 1X PCR buffer (Applied Biosystems, Foster City, CA, USA) 1.5 
mM MgCl2, 25 pmol of each primer, 200 µM dNTPs and 3 U Taq DNA Polymerase 
(Promega, Madison, WI, USA). Cycling conditions were: one cycle of 1 min at 95ºC, 30 
sec at 63.7ºC, 30 sec at 72ºC followed by 34 additional cycles of 30 sec at 94ºC, 30 sec at 
63.7ºC, 30 sec at 72ºC and a final extension of 3 min at 72 0C.  
The resulting PCR products were electrophorized in a 1.5% agarose (Fischer, Pittsburgh, 
PA, USA) gel and stained with 5 µl of ethidium bromide (10mg/ml). The PCR products 
visualized on the gel were cut and the DNA was extracted from the gel fragment. 
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Gel Extraction 
 The DNA was extracted from the gel fragment using the Qiagen gel extraction kit 
(Qiagen, Valencia, CA, USA) according to manufacturer’s protocols. Briefly, 3 volumes 
of buffer QG was added to the gel fragment and was incubated at 50ºC for 10 min (until 
the gel slice was completely dissolved). To the dissolved gel 1 volume of isopropanol 
was added and the sample was placed in a QIAquick column. The sample was 
centrifuged at 13,000 rpm for 1 min. The flow-through was discarded and 0.75 ml of 
buffer PE was added to the sample. The sample was centrifuged twice at 13,000 rpm for 
1 min. The column was placed in a fresh tube and the DNA was eluted using 30 µl of 
dH2O. The gel purified DNA was used as template for PCR. The PCR product obtained 
was TA cloned and sequenced to confirm its identity. 
 
TA Cloning 
The PCR product was TA cloned using TOPO® TA cloning kit according to 
manufacturer’s protocol (Invitrogen, Carlsbad, CA, USA). Briefly, fresh PCR products 
were ligated to vector pCR®2.1-TOPO® by incubating at room temperature for 20 min. 
The 6 µl  ligation mix contained 2 µl of fresh PCR product, 1 µl of pCR®2.1-TOPO® 
vector, 1 µl of salt solution, and 2 µl of water. Two microliters of the ligated PCR product 
was added to 25 µl vial of chemically competent cells and incubated on ice for 30 min. 
The cells were heat-shocked for 30 sec at 42ºC without shaking. SOC medium (250 µl)  
was added to the heat-shocked cells and incubated at 37ºC for an hour on a shaker (225 
rpm). Each transformation was spreaded on YT plates containing X-gal (40 mg/ml) and 
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ampicillin (50 µg/ml). The plates were incubated at 37ºC overnight. Positive white clones 
were selected and further analyzed using cell burst PCR. 
 
“Cell Burst” PCR      
A small sample of a bacterial colony was collected on a toothpick, mixed in 30 µl of 
water and heated at 95ºC for 5 min to lyse cells. One microliter of this cell lysis was used 
for PCR using specific primers to select positive clones containing the fragment of 
interest.  
Sequencing Reaction 
The PCR products generated through cell burst-PCR were treated with shrimp alkaline 
phosphatase (1u µl-1) and Exonuclease III (10u µl-1) at a volume equaling 5% of the PCR 
product and was incubated at 37 °C for 30 min followed by 80°C for 10 min. Sequencing 
reactions were performed in a 10 µl reaction mix containing 2 µl PCR product, 1 mM 
sequencing primer, 2 µl of BigDye dye terminator mix (Applied Biosystems, Foster City, 
CA, USA) and 1µl buffer (400 mM Tris, pH 9, 10 mM MgCl2). Cycling conditions were: 
60 cycles of 30 sec at 95°C, 20 sec at 50°C, and 4 min at 60°C. Sequencing reactions 
were cleaned using DTR Gel Filtration columns (Edge Biosystems, Gaithersburg, MD, 
USA) and analyzed on an ABI 3700 DNA analyzer (Applied Biosystems, Foster City, 
CA, USA). The sequences generated were analyzed using Basic Local Alignment Search 
Tools (BLAST) available at NCBI. 
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Evaluation of Kallikrein 1 (KLK1) and 14 (KLK14) Gene Expression 
As sequence information was not available for pig KLK1 and KLK14, homology 
searches were carried out at NCBI (http://www.ncbi.nlm.nih.gov) and TIGR (The 
Institute of Genomic Research; http://www.tigr.org/) database using published pig KLK4 
sequence. Homologous sequences identified were used to develop primers based on 
human-pig homology using primer 3 software (Rozen and Skaletsky 2000). Table 10 
shows the primer sequences used for RT-PCR.  
 
Table 10. Primer sequences used for PCR amplification of KLK1 and KLK14 
using RT-PCR. 
Primer Sequence 5'-3' Length (bp) 
PCR 
Product 
Size 
(bp) 
Tm Used 
P KLK-1 F GGACTACAGCCACGACCTCATGCTGC 26 297 62ºC 
P KLK-1 R CACCCATACAGGTGTCCTTGCCACCT 26   
P KLK-14 F ATGTTCCTCCTGCTGACAGCACTTCA 26 321 60ºC 
P KLK-14 R GTGGGTCCGGGAGTTGTACT 20   
 
The primer sets developed were optimized and used to evaluate gene expression in 
pregnant (d10, d12, d15 and d18) and cyclic (d0, d5, d10, d12, d15, and d18) 
endometrium using RT-PCR. Gene expression of KLK1 and KLK14 were also evaluated 
in conceptus tissue (d12, d14, d16) using RT-PCR. The PCR reactions were performed in 
a MJ Dyad thermal cycler (MJ Research Inc., Waltham, MA, USA). For KLK1 a 20 µl 
reaction mix contained 1 µl cDNA, 1X PCR buffer (Applied Biosystems, Foster City, 
CA, USA) 1.5 mM MgCl2, 25 pmol of each primer, 200 µM dNTPs and 3 U Taq DNA 
Polymerase (Promega, Madison, WI, USA). Cycling conditions were: one cycle of 1 min 
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at 95ºC, 30 sec at 62ºC, 30 sec at 72ºC followed by 34 additional cycles of 30 sec at 
94ºC, 30 sec at 62ºC, 30 sec at 72ºC and a final extension of 3 min at 72 0C. 
For KLK14 Advantage-GC cDNA PCR amplification kit was used (BD Biosciences, 
Palo Alto, CA, USA). A 25 µl reaction mix contained 1 µl cDNA, 1X GC cDNA PCR 
reaction buffer (BD Biosciences, Palo Alto, CA, USA), 1 M GC melt (BD Biosciences, 
Palo Alto, CA, USA),  25 pmol of each primer, 200 µM dNTPs and 1X Advantage-GC 
cDNA Pol. mix (BD Biosciences, Palo Alto, CA, USA). Cycling conditions were: one 
cycle of 1 min at 95ºC, 30 sec at 60ºC, 30 sec at 68ºC followed by 34 additional cycles of 
30 sec at 94ºC, 30 sec at 60ºC, 30 sec at 68ºC and a final extension of 3 min at 72 0C.    
The resulting PCR products were electrophorized in a 1.5% agarose (Fischer, Pittsburgh, 
PA, USA) gels and stained with 5 µl of ethidium bromide (10 mg/ml). The PCR products 
visualized on the gel were cut and the DNA was extracted from the gel fragment as 
previously described, PCR amplified and sequenced to confirm its identity. 
 
Quantitative Real Time PCR  
Endometrial and conceptus gene expression for KLK1, KLK4, and KLK14 was 
quantified using one-step reverse transcriptase-polymerase chain reaction (RT-PCR) after 
DNase treatment.  One step qRT-PCR kit (Eurogentec, San Diego, CA, USA) was used 
for quantitative gene expression analysis. Primers and probes for KLK1,  KLK4, and 
KLK14 were developed using available Genbank sequence for KLK4 and KLK1 and 
KLK14 sequences identified through RT-PCR using primer 3 software (Rozen and 
Skaletsky 2000). All dual-labeled probes were designed to have an intron in the middle 
with a 5' reporter dye (6-FAM) and a 3' quenching dye (TAMRA) (table 11). The qRT-
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PCR reactions were performed in an ABI PRISM 7500 sequence detection system 
(Applied Biosystems, Foster City, CA). Total reaction volume of 25 µl contained 400 nM 
forward primer, 400 nM reverse primer, 200 nM dual labeled fluorescent probe, 1X 
Master mix, 12.5 U of reverse transcriptase and 100 ng of total RNA. Thermal cycling 
conditions were 48°C for 30 min, 95°C for 10 min, followed by 45 additional cycles of  
95°C for 15 sec and 60°C for 1 min for KLK1 and 68°C for 1 min for KLK14. 
Ribosomal 18S RNA (18S, RNA Control Kit (Eurogenetec, Philadelphia, PA, USA) was 
assayed according to manufacturer’s protocol for each sample for normalization. 
Following qRT-PCR, quantification of gene expression was made by setting the threshold 
cycle (CT) in the geometric amplification phase of the plot. Relative quantification of 
gene expression was evaluated using the comparative CT method as described previously 
by Hettinger et al. (2001). The CT value was determined by subtracting the gene CT 
value of each sample from the corresponding sample ribosomal 18S CT value. Calculation 
of CT was carried out using the highest mean CT value as an arbitrary constant to 
subtract from all other CT mean values. Fold changes in gene expression are calculated 
from the CT values using the formula 2- Ct.  
 
Statistical Analysis  
Endometrial gene expression ( CT value) was analyzed with least squares using the 
PROC MIXED of SAS. The statistical model tested the effect of day, reproductive status 
(cyclic and pregnant), and the day x reproductive status interaction. Results are presented 
as least square means ± standard error of the mean.  
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Table 11. Primers and probes used for real-time PCR. Primers and probes 
were developed with an intron in the middle to prevent genomic DNA 
amplification using software available at IDT (Integrated DNA 
Technologies)(http://scitools.idtdna.com/Primerquest/). 
Primer Sequence 5'-3' 
Lengt
h 
(bp) 
PCR 
Product 
Size 
(bp) 
KLK1-F GGACTACAGCCACGACCTCATGCTGC 26 171 
KLK1-R GTCGGGGAATTCGAAGTCGTCTGG 24  
KLK1-P  TGGAGCTGCCCACCCAGGAACCCGAA 26  
KLK4-F  ATCCGCAATGGGTGCTGTCA 20 92 
KLK4-R GGGTTCTTGTTCGGGCTCAAGATT 24  
KLK4-P  ATTCCTACACCATCGGGCTGGGTC 24  
KLK14-F ATGTTCCTCCTGCTGACAGCACT 23 155 
KLK14-R CAGAGGAAACGATGCCAGGGACC 23  
KLK14-P GCCACGGCACAGAGCCAGGGCAATGAGAACAAGATAAT 38  
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Results 
Kallikrein1 gene expression analysis  
RT-PCR amplification of kallikrein 1 using homologous sequence information allowed 
the amplification of a 297 bp PCR product. This product had an e value of (P< e-143)  
(98% homology) to a recently submitted porcine kallikrein1 mRNA sequence (accession 
# NM_001001911) and (P< e-16) (87% homology) to human kallikrein 1, 
renal/pancreas/salivary mRNA (accession # BT007253). This primer set also generated a 
larger fragment of ~450 bp with genomic DNA (Fig. 12A).  
RT-PCR amplification of kallikrein 1 in cyclic and pregnant endometrium revealed its 
expression during days 0, 5, 10, 12, 15 and 18 of the estrous cycle and days 10, 12, 15 
and 18 in the pregnant endometrium (Fig.12 A and B) RT-PCR  amplification of 
conceptus RNA indicated that kallikrein 1 was expressed on days 12, 14 and 16 (Fig.13). 
The endometrial and conceptus gene expression of kallikrein 1 was also quantified using 
quantitative real-time PCR (qRT-PCR) on days 0, 5, 10, 12, 15, and 18 of the estrous 
cycle and days 10, 12, 15, and 18 in the pregnant endometrium and days 10-17 of 
conceptus development. Kallikrein 1 gene expression was detected across all days of the 
estrous cycle and early pregnancy. No significant day or status difference was detected 
for endometrial or conceptus kallikrein 1 gene expression (Tables 12 and 13). 
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Figure 12 
 
Ethidium bromide-stained 1.5% agarose gels of kallikrein 1 expression in cyclic and 
pregnant endometrium. 
 
A. 
A 297 bp PCR product corresponding to the mRNA transcript of kallikrein 1 was 
detected, while a ~450 bp PCR corresponding to the genomic fragment of kallikrein 1 
was also detected. The bands were cut and sequenced to confirm its identity. The 
expression of kallikrein 1 on days 12 and 18 of the estrous cycle are not visible, but was 
detected and is shown in fig. 12B.  
 
B.  
Kallikrein 1 gene expression after DNase treatment. After DNase treatment the ~450 bp 
PCR product corresponding to genomic DNA was not present.  The expression of 
kallikrein 1 on day 15 is not visible, but was detected and is shown in figure 12A. Beta-
actin was run as a positive control. 
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Figure 12A 
 
297 bp 
~450 bp 
 
 
Figure 12B 
 
297 bp 
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Figure 13 
 
A 297 bp PCR product corresponding to Kallikrein 1 gene expression was detected on 
days 12, 14 and 16 of conceptus development. The expression of Kallikrein 1 was low 
during conceptus development. Beta-actin was run as a control. 
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Table 12 
 
Endometrial kallikrein1 gene expression across days of the estrous cycle and early 
pregnancy using the comparative CT method. 
 
    Kallikrein 1 18S     
Day Status average CT∗ average CT* ∆CT† ∆∆CT‡ 
0 Cyclic 32.00 ± 0.62 6.02 ± 0.22 25.97 ± 0.71 0.00 
5 Cyclic 29.97 ± 0.62 6.34 ± 0.22 23.63 ± 0.71 -2.34 
10 Cyclic 30.82 ± 0.53 6.37 ± 0.19 24.45 ± 0.62 -1.53 
 Pregnant 30.29 ± 0.62  5.85 ± 0.22 24.44 ± 0.71 -1.53 
12 Cyclic 29.78 ± 0.62  6.43 ± 0.22 23.36 ± 0.71 -2.62 
 Pregnant 31.20 ± 0.96  6.19 ± 0.29 25.00 ± 0.62 -0.97 
15 Cyclic 31.78 ± 0.53  6.49 ± 0.19 25.29 ± 0.62 -0.68 
 Pregnant 32.33 ± 0.62  6.36 ± 0.22 25.97 ± 0.71 0.00 
18 Cyclic 31.14 ± 0.53  6.32 ± 0.19 24.82 ± 0.61 -1.15 
  Pregnant 30.49 ± 0.53 6.44 ± 0.19 24.04 ± 0.61 -1.93 
 
*CT = Cycle threshold: Cycle number where amplification crosses the threshold set in 
the geometric portion of the amplification curve. 
†∆CT  = kallikrein 1 CT – 18S ribosomal CT: Normalization of RT-PCR cycles for 
kallikrein 1 target with 18S ribosomal RNA. No gene expression change was detected 
(P<0.01). 
‡∆∆CT = Least square means of ∆CT – highest Least square mean of ∆CT value: the 
least square estimates of day 15 pregnant and day 0 cycling (highest ∆CT ; lowest 
expression of target in study) was used as a calibrator to set the baseline to compare 
mean differences in ∆CT values across all days. 
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Table 13 
 
Conceptus kallikrein1 gene expression during early embryonic development using the 
comparative CT method. 
 
    Kallikrein 1 18S     
Day Status average CT∗ average CT* ∆CT† ∆∆CT‡ 
10 Conceptus     30.67 ± 0.34 6.52 ± 0.19 24.15 ± 0.31 -1.19 
11 Conceptus 30.27 ± 0.34 5.97 ± 0.19 24.30 ± 0.31 -1.04 
12 Conceptus 30.42 ± 0.34  6.12 ± 0.19  24.31 ± 0.31  -1.03 
13 Conceptus 30.50 ± 0.45  6.11 ± 0.25  24.38 ± 0.40  -0.95 
14 Conceptus 30.96 ± 0.38  5.63 ± 0.22 25.34 ± 0.34 0.00 
15 Conceptus 30.87 ± 0.45  5.94 ± 0.25  24.93 ± 0.40  -0.41 
16 Conceptus 30.91 ± 0.38 5.69 ± 0.22 25.22 ± 0.34 -0.12 
17 Conceptus 30.69 ± 0.38 6.17 ± 0.22 24.53 ± 0.34 -0.81 
 
*CT = Cycle threshold: Cycle number where amplification crosses the threshold set in 
the geometric portion of the amplification curve. 
†∆CT  = kallikrein 1 CT – 18S ribosomal CT: Normalization of RT-PCR cycles for 
kallikrein 1 target with 18S ribosomal RNA. No gene expression change was detected 
(P<0.05).   
‡∆∆CT = Least square means of ∆CT – highest Least square mean of ∆CT value: the 
least square estimates of day 16 (highest ∆CT ; lowest expression of target in study) 
was used as a calibrator to set the baseline to compare mean differences in ∆CT values 
across all days. 
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Kallikrein 4 gene expression analysis    
Kallikrein 4 gene expression using RT-PCR detected a 247 bp PCR product. The 247 bp 
fragment was clearly detected on days 0, 5, 10, 12, 15 and 18 of the estrous cycle and 
days 10, 12, 15 and 18 in the pregnant endometrium but was not detected with genomic 
DNA (Fig.14). In the conceptus kallikrein 4 gene expression was detected on day 12 and 
14 but was low on day 16 (Fig.15). Quantitative real-time PCR analysis of kallikrein 4 in 
the endometrium (Table 14) revealed a day effect (P<0.05) and status effect (P<0.01), 
but did not detect a day by status interaction. During the estrous cycle, endometrial 
kallikrein 4 is expressed higher in cyclic animals compared to pregnant animals (Fig.16). 
Kallikrein 4 expression was elevated in day 0, 5, and 10 of the estrous cycle, while the 
expression of kallikrein 4 was down-regulated on day 12, 15 and 18 (Fig.16).  
Quantitative real-time PCR of kallikrein 4 expression in the conceptus (Table 15) 
detected a day effect (P<0.01). Kallikrein 4 expression was 2.5 fold higher on days 10, 
11, 12 and 13 compared to day 17. After day 13 there was a gradual decrease of 
kallikrein 4 expression in the conceptus (Fig. 17). Comparison of kallikrein 4 expression 
in the conceptus and the pregnant endometrium revealed that the gene is 16-17 fold 
highly expressed in the conceptus. 
 
 
 
 
 
 
 109
Figure 14 
 
Ethidium bromide-stained 1.5% agarose gel of kallikrein 4 expression in cyclic and 
pregnant endometrium. A 247 bp PCR product corresponding to the mRNA transcript of 
kallikrein 4 was detected on days 0, 5, 10, 12, 15, and 18 of the estrous cycle and days 
10, 12, 15, and 18 of pregnant endometrium. No PCR amplification was detected for 
genomic DNA. The band corresponding to kallikrein 4 was cut and sequenced to confirm 
its identity.  
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Figure 15 
 
 
A 247 bp PCR product corresponding to Kallikrein 4 gene expression was detected on 
days 12, 14 and 16 of conceptus development. The expression of Kallikrein 4 was low on 
day 16 and was hardly detectable. Beta-actin was run as a control. 
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Table 14 
 
Endometrial kallikrein 4 gene expression across days of the estrous cycle and early 
pregnancy using the comparative CT method. 
 
    Kallikrein 4 18S     
Day Status average CT∗ average CT* ∆CT† ∆∆CT‡ 
0 Cyclic 29.52 ± 0.58 18.53 ± 0.33 11.00 ± 0.56 -2.73 
5 Cyclic 28.34 ± 0.66 18.42 ± 0.38 9.92 ± 0.65 -3.80 
10 Cyclic 28.45 ± 0.58 18.64 ± 0.33 9.82 ± 0.57 -3.90 
 Pregnant 30.80 ± 0.67 18.51 ± 0.38 12.30 ± 0.65 -1.42 
12 Cyclic 30.45 ± 0.58  19.02 ± 0.33 11.46 ± 0.56 -2.26 
 Pregnant 30.68 ± 0.58  18.29 ± 0.33 12.39 ± 0.56 -1.33 
15 Cyclic 30.79 ± 0.58 18.34 ± 0.33 12.45 ± 0.56 -1.27 
 Pregnant 30.75 ± 0.67  18.44 ± 0.38 12.31 ± 0.65 -1.41 
18 Cyclic 30.36 ± 0.58 18.45 ± 0.33 11.90 ± 0..56 -2.63 
  Pregnant 32.90 ± 0.58 19.15 ± 0.33 13.72 ± 0.56 0.00 
 
*CT = Cycle threshold: Cycle number where amplification crosses the threshold set in 
the geometric portion of the amplification curve. 
†∆CT  = kallikrein 4 CT – 18S ribosomal CT: Normalization of RT-PCR cycles for 
kallikrein 4 target with 18S ribosomal RNA. There was a status effect (P<0.01) and a 
day effect (P<0.05). No day x status interaction was detected (P<0.05).  
‡∆∆CT = Least square means of ∆CT – highest Least square mean of ∆CT value: the 
least square estimates of day 18 pregnant (highest ∆CT ; lowest expression of target in 
study) was used as a calibrator to set the baseline to compare mean differences in ∆CT 
values across all days. 
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Figure 16 
 
Fold gene expression of kallikrein 4 in endometrium of cyclic and pregnant gilts 
generated using quantitative one-step RT-PCR. 
Quantitative real-time PCR analysis of kallikrein 4 detected a status effect (cyclic or 
pregnant) (P<0.01) in the endometrium. During the estrous cycle, endometrial kallikrein 
4 is expressed higher in cyclic animals compared to pregnant animals. The fold changes 
in expression was calculated from the differences of least squares means of ∆CT values 
using the formula 2-∆∆CT. Columns with different superscripts represent significant 
differences (P<0.01) in ∆CT values.  
Quantitative real-time PCR analysis of kallikrein 4 also detected a day effect (P<0.01). 
The fold changes in expression was calculated from the differences of least squares 
means of ∆CT values using the formula 2-∆∆CT. Columns with different superscripts 
represent significant differences (P<0.05) in ∆CT values for each day.  
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Table 15 
 
Conceptus kallikrein 4 gene expression across days of embryo development using the 
comparative CT method. 
 
  Kallikrein 4 18S   
Day Status average CT∗ average CT* ∆CT† ∆∆CT‡ 
10 Conceptus 25.45 ± 0.33 6.52 ± 0.19 18.93 ± 0.33 -1.95 
11 Conceptus 24.91 ± 0.33 5.97 ± 0.19 18.94 ± 0.33 -1.93 
12 Conceptus 25.37 ± 0.33  6.12 ± 0.19 19.26 ± 0.33 -1.62 
13 Conceptus 25.33 ± 0.43  6.11 ± 0.25 19.21 ± 0.43 -1.67 
14 Conceptus 25.08 ± 0.37  5.63 ± 0.22 19.45 ± 0.37 -1.43 
15 Conceptus 26.07 ± 0.43  5.94 ± 0.25 20.12 ± 0.43 -0.76 
16 Conceptus 25.86 ± 0.37 5.69 ± 0.22 20.17 ± 0.37 -0.71 
17 Conceptus 27.05 ± 0.37 6.17 ± 0.22 20.88 ± 0.37 0.00 
 
*CT = Cycle threshold: Cycle number where amplification crosses the threshold set in 
the geometric portion of the amplification curve. 
†∆CT  = kallikrein 1 CT – 18S ribosomal CT: Normalization of RT-PCR cycles for 
kallikrein 1 target with 18S ribosomal RNA. Day effect (P<0.05) was detected.  
‡∆∆CT = Least square means of ∆CT – highest Least square mean of ∆CT value: the 
least square estimates of day 17 (highest ∆CT ; lowest expression of target in study) 
was used as a calibrator to set the baseline to compare mean differences in ∆CT values 
across all days. 
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Figure 17 
 
Quantitative real-time PCR analysis of kallikrein 4 in the conceptus showing a day effect 
(P<0.01). The fold changes in gene expression was calculated from the ∆∆CT values 
using the formula 2-∆∆CT. Columns with different superscripts represent significant 
differences (P<0.05) in ∆CT values.  
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Kallikrein 14 gene expression analysis   
RT-PCR amplification of kallikrein 14 using homologous sequence information allowed 
the amplification of a 321 bp PCR product. This product has high homology to human 
kallikrein 14 mRNA sequence (accession # AF283670) (P< e-63) (86% homology). It also 
has high homology to rat glandular kallikrein 14 (accession # XM_218641) and mouse 
kallikrein 14 (accession # BC044756) with P< e-18 (81% homology) and  P< e-13 (82% 
homology) respectively. This primer set also generated a larger fragment of ~400 bp with 
genomic DNA.  
RT-PCR amplification of kallikrein 14 in cyclic and pregnant endometrium indicated that 
KLK14 was expressed during days 0, 12, 15 and 18 of the estrous cycle and days 12, 15 
and 18 of pregnancy (Fig. 18). Only a very faint band was detected on days 5 and 10 of 
the estrous cycle and day 10 of pregnancy even with greater amounts of cDNA. RT-PCR 
amplification of kallikrein 14 conceptus gene expression was detected in day 12 and 14 
conceptus tissue but was very low in day 16 conceptuses (Fig. 19).  
The endometrial and conceptus kallikrein 14 gene expression was analyzed using 
quantitative real-time PCR. The real-time PCR data confirmed the results of RT-PCR, as 
no amplification was visible on day 5 and 10 cyclic and day 10 pregnant endometrium 
after 40 cycles of amplification (Fig. 20). Therefore, for data analyzing purposes we 
assigned an arbitrary CT value of 40 cycles to day 5 and 10 cyclic and day 10 pregnant 
endometrium. A highly significant day effect of (P<0.01) was detected for endometrial 
kallikrein 14 gene expression during the estrous cycle and pregnant endometrium (Table 
16). The quantitative real-time PCR analysis of the conceptus (Table 17) revealed a day 
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effect (P<0.05) where the expression of kallikrein 14 was down-regulated by day 17 (Fig. 
21). 
 121
Figure 18  
 
Ethidium bromide-stained 1.5% agarose gel of kallikrein 14 expression in cyclic and 
pregnant endometrium. A 321 bp PCR product corresponding  to the mRNA transcript of 
kallikrein 14 was detected, while a ~420 bp fragment was detected off genomic DNA. 
The band corresponding to kallikrein 14 mRNA was cut and sequenced to confirm its 
identity. The RT-PCR amplification detect endometrial kallikrein 14 gene expression at 
very low levels on days 5 and 10 of estrous cycle and day 10 of pregnancy. 
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Figure 19 
 
A 321 bp PCR product corresponding to Kallikrein 14 gene expression was detected on 
day 12 and 14 conceptuses. The expression of kallikrein 16 was undetectable, but the 
beta-actin shows that the amount of day 16 cDNA used was lower. Therefore the low 
amounts of kallikrein 14 on day 16 conceptuses may be due to low amounts of cDNA 
added. Beta-actin was run as a control. 
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Table 16 
 
Endometrial kallikrein 14 gene expression across days of the estrous cycle and early 
pregnancy using the comparative CT method. No amplification was detected on days 5 
and 10 of cycling and day 10 of pregnancy after 40 cycles of PCR amplification. 
Therefore, an arbitrary value of 40 was used as the CT∗ value for days 5 and 10 of cycling 
and day 10 of pregnancy to calculate  ∆CT† and ∆∆CT‡ values. 
 
    Kallikrein 14 18S     
Day Status average CT∗ average CT* ∆CT† ∆∆CT‡ 
0 Cyclic 26.48 ± 0.72 6.02 ± 0.22 19.81 ± 0.65 -13.85 
5 Cyclic Undetected (40) 6.34 ± 0.22 33.66 ± 0.75 0.00 
10 Cyclic Undetected (40) 6.37 ± 0.19 33.62 ± 0.65 -0.04 
 Pregnant Undetected (40) 5.85 ± 0.22 34.15 ± 0.75 -0.49 
12 Cyclic 26.50 ± 0.83  6.43 ± 0.22 20.07 ± 0.75 -13.6 
 Pregnant 25.65 ± 0.72  6.19 ± 0.29 19.46 ± 0.65 -14.21 
15 Cyclic 25.94 ± 0.72 6.49 ± 0.19 19.45 ± 0.65 -14.21 
 Pregnant 25.98 ± 0.83  6.36 ± 0.22 19.62 ± 0.75 -14.04 
18 Cyclic 25.65 ± 0.72  6.32 ± 0.19 19.33 ± 0.65 -14.33 
  Pregnant 25.02 ± 0.23 6.44 ± 0.19 18.58 ± 0.65 -15.09 
 
  *CT = Cycle threshold: Cycle number where amplification crosses the threshold set 
in the geometric portion of the amplification curve. 
†∆CT  = kallikrein 1 CT – 18S ribosomal CT: Normalization of RT-PCR cycles for 
kallikrein 1 target with 18S ribosomal RNA. A day effect was detected (P<0.05). 
‡∆∆CT = Least square means of ∆CT – highest Least square mean of ∆CT value: the 
least square estimates of day 5 cycling (highest ∆CT ; lowest expression of target in 
study) was used as a calibrator to set the baseline to compare mean differences in ∆CT 
values across all days. 
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Figure 20 
 
Kallikrein 14 gene expression across days of the estrous cycle and early pregnancy. The 
fold a changes in gene expression was calculated from the ∆∆CT values using the formula 
2-∆∆CT. Kallikrein 14 expression was not detected on days 5 and 10 of the estrous cycle 
and day 10 of pregnant endometrium. Therefore, an arbitrary value of 40 was used as the 
CT∗ value for days 5 and 10 of cycling and day 10 of pregnancy to calculate changes in 
gene expression. Columns with different superscripts represent significant differences 
(P<0.01) in ∆CT values. 
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Table 17 
 
Conceptus kallikrein 14 gene expression across days of embryo development using the 
comparative CT method. 
 
    Kallikrein 14  18S     
Day Status average CT∗ average CT ∆CT ∆∆CT
10 Conceptus 32.39 ± 0.39 6.52 ± 0.19 25.87 ± 0.37 -2.57 
11 Conceptus 31.96 ± 0.39 5.97 ± 0.19 25.99 ± 0.37 -2.45 
12 Conceptus 31.39 ± 0.44  6.12 ± 0.19 25.45 ± 0.41  -2.99 
13 Conceptus 32.29 ± 0.51  6.11 ± 0.25 26.17 ± 0.48  -2.27 
14 Conceptus 32.36 ± 0.44  5.63 ± 0.22 26.73 ± 0.41  -1.71 
15 Conceptus 32.60 ± 0.51  5.94 ± 0.25 26.66 ± 0.48 -1.78 
16 Conceptus 31.89 ± 0.44 5.69 ± 0.22 26.20 ± 0.41 -2.24 
17 Conceptus 34.61 ± 0.62 6.17 ± 0.22 28.44 ± 0.59 0.00 
 
*CT = Cycle threshold: Cycle number where amplification crosses the threshold set in 
the geometric portion of the amplification curve. 
†∆CT  = kallikrein 1 CT – 18S ribosomal CT: Normalization of RT-PCR cycles for 
kallikrein 1 target with 18S ribosomal RNA. A day effect was detected (P<0.05). 
‡∆∆CT = Least square means of ∆CT – highest Least square mean of ∆CT value: the 
least square estimates of day 17 (highest ∆CT ; lowest expression of target in study) 
was used as a calibrator to set the baseline to compare mean differences in ∆CT values 
across all days. 
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Figure 21 
 
Quantitative real-time PCR analysis of kallikrein 14 in the conceptus showing a day 
effect (P<0.05). The fold changes in gene expression was calculated from the ∆∆CT 
values using the formula 2-∆∆CT. Columns with different superscripts represent significant 
differences (P<0.05) in ∆CT values.  
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Discussion 
Many physiological events involved in implantation/placental attachment such as 
vasodilation, prostaglandin synthesis, and proteolytic tissue remodeling  mimic 
inflammatory responses (Vonnahme et al. 2003). Many of these inflammatory like 
immunological responses are known to be caused by the kallikrein-kininogen-kinin 
system. During the time of maternal recognition of pregnancy until the time of conceptus 
attachment, many alterations occur in the porcine uterine lumen. These changes are 
similar to an acute inflammatory response, where the rapid elongation and growth of the 
conceptus, and the estrogen synthesis by the conceptuses can alter uterine secretion of 
proteins (Roberts et al. 1993), prostaglandins (Bazer and Thatcher 1977), uterine blood 
flow (Ford et al. 1982) and uterine cellular morphology (Geisert et al. 1982a,b). During 
the estrous cycle and early pregnancy, LMW and HMW kininogen are present in the 
porcine endometrium indicating that the kallikrein-kininogen kinin system is active in the 
pig (Allen et al. 2002;  Vonnahme et al. 2003). Tissue kallikreins are known to regulate 
the activation of many growth factors (Vonnahme et al 1999 & 2003) and to cleave inter-
α-trypsin inhibitor heavy chain 4 in the porcine endometrium (Hashimoto et al. 1996; 
Geisert et al. 1998). Detection of kallikrein 1 which cleaves LMW kininogen to release 
bradykinins (Allen at al. 2002) in the porcine endometrium and conceptus suggests that 
this serine protease may be involved in the release of lysl-bradykinin through the 
proteolytic cleavage of low molecular weight kininogen. The detection of kallikrein both 
in the conceptus and endometrium also suggests that kallikrein 1 may exert a local effect 
on the endometrium and conceptus. As no significant gene expression change was 
detected in cyclic and pregnant endometrium and conceptus, kallikrein 1 may be secreted 
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as an inactive prekallikrein which needs to be activated to exert its kininogenase activity. 
Although, the expression of kallikrein 1 was detected during this study, the activity and 
function of kallikrein 1 needs to be investigated more closely.  
In the present study changes in tissue kallikrein 1 expression was not detected, but the 
detection of tissue kallikrein expression in the conceptus suggests that the conceptus 
exerts its own kininogenase activity independent of the endometrium, therefore it is 
possible that the conceptus may be regulating the cleavage of HMW and LMW kininogen 
to release kinins during early embryonic development.      
Tissue kallikrein release of kinins through proteolytic cleavage of low molecular weight 
kininogen has recently received increased attention in therapeutic angiogenesis. This 
release of kinins together with the presence of kinin- β type 2 receptor during days 10 and 
15 of pregnancy in the pig (Allen et al. 2002) suggests that kallikreins may play an 
important role in early embryonic development in the pig. The stabilization of the uterine 
epithelium extracellular matrix through proteolytic cleavage of inter-α-trypsin heavy 
chain 4 (Geisert et al. 1998) further suggests that tissue kallikrein helps in conceptus 
attachment and early embryonic survival in the pig by exerting several biologically 
important processors essential for conceptus elongation and traphoblast attachment in the 
pig.  
Another member of the tissue kallikrein gene family, kallikrein 4, is expressed in an 
endometrial cancer cell line (Mayers and Clements 2001). Patho-physiology of such 
cancers are attributed to estrogen and progesterone acting through the regulation of 
specific genes (Mayers and Clements 2001). Recently, kallikrein 4 gene expression was 
demonstrated to be increased by progestins in a breast cancer cell line, BT-474 (Mayers 
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and Clements 2001) indicating that kallikrein 4 may be regulated by progesterone. Also, 
kallikrein 4 gene expression is increased by estrogen and progesterone alone, and in 
combination, in KLE cell line which has a defective estrogen receptor (Mayers and 
Clements 2001). Kallikrein 4 expression was elevated 3-4 fold higher in day 0-12 cyclic 
and pregnant gilts compared to day 12-18 cyclic and pregnant endometrium in our study, 
suggesting that kallikrein 4 expression in the porcine endometrium may be regulated by 
the progesterone receptor which is elevated in the uterine epithelium during this period. 
Furthermore, potential androgen response elements (AREs) have been identified in the 5’ 
flanking region of kallikrein 4 (Mayers and Clements 2001) . These androgen response 
elements have not yet been characterized, but as the progesterone receptor can bind to 
similar androgen response elements and the detection of kallikrein 4 gene regulation in 
human breast cancer cell line BT-474 (Mayers and Clements 2001) further speculates that 
the progesterone receptor may bind to these androgen response elements present in the 5’ 
flanking region of kallikrein 4 to regulate KLK4 gene expression.  
Furthermore, kallikrein 4 is expressed in the porcine dental enamel (Ryu et al. 2002). In 
the porcine dental enamel kallikrein 4 is expressed during early transition and maturation 
stages of enamel formation where kallikrein 4 participates in the degradation of enamel 
proteins (Ryu et al. 2002). Kallikrein 4, which is expressed in the inactive prekallikrein 
form needs to be activated to exert its protease activity. MMP-20 is seen to be 
coexpressed with kallikrein 4 in the odontogenic tissue, suggesting that MMP-20 may be 
involved with the activation of kallikrein 4 (Ryu et al. 2002). The ability of kallikrein 4 to 
cleave a broad range of peptides and its higher expression on days 0, 5 and 10 in cyclic 
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and pregnant endometrium suggests that kallikrein 4 may also play a role in extra-cellular 
matrix remodeling in the endometrium.     
The greater expression of kallikrein 4 in the conceptus with respect to endometrial 
expression suggests that kallikrein 4 plays a role in early conceptus development. The 
real-time PCR data suggests a 4 fold increase of kallikrein 4 expression in day 10-13 of 
conceptus development which gradually decreases from day 15 to 17 of conceptus 
development. This is the time when the conceptus starts cell proliferation and placental 
membrane formation occurs, therefore, this suggests that kallikrein 4 may be one of the 
factors that help conceptus attachment, extracellular matrix degradation and cellular 
remodeling. More studies need to be carried out on kallikrein 4 to identify the substrate 
specificity and its biological role during early embryonic development.  
The newly identified porcine tissue kallikrein 14 is regulated by androgen receptors. 
Previous studies have shown that kallikrein 14 is up-regulated in breast, prostate and 
ovarian cancers and is regulated by androgen and androgen receptor pathways (Yousef et 
al 2002; & 2003). The expression of kallikrein 14 in the secretory epithelial cells of 
benign prostate gland (Yousef et al. 2002) and in the prostatic intraepithelial neoplasia 
(Hooper et al. 2001) and the up-regulation of kallikrein 14 by dihydrotestesterone (4-
fold) and estradiol (38-fold) in breast cancer cell lines (Borgono et al. 2003; Yousef et al. 
2003) further suggests that kallikrein 14 may be regulated by an androgen receptor. 
Endometrial kallikrein 14 was up-regulated on day 0 and days 12-18 in cyclic and 
pregnant gilts suggesting that kallikrein 14 may be regulated by the loss of progesterone 
receptor in the uterine epithelium. 
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In 1998, Lee et al. (1998) reported the degradation of several insulin-like growth factor 
binding proteins by an unknown serine protease. The serine protease degradation of the 
IGFBP was absent during the spherical stage of conceptus development, but the IGFBP-2 
and 3 was completely removed when tubular and filamentous conceptuses were present 
(Geisert et al. 2001; Vonnahme et al. 1999). Kallikreins are serine proteases that may be 
involved in the breakdown of IGFBPs directly or indirectly through activation of matrix 
metalloproteinases. Protease activity towards IGFBPs on day 12 and 15 pregnant and 
cycling gilt uterine flushings has been detected (Geisert et al. 2001) and specific 
inhibitors to kallikrein and matrix metalloproteinases has shown to inhibit porcine 
IGFBP-2, -3, and -5 degradation (Vonnahme et al. 1999; Geisert et al. 2001). The 
increased expression kallikrein 14 on day 12-18 of pregnant and cyclic endometrium 
suggests that kallikrein 14 may play a role in the break-down of IGFBPs to stimulate the 
release of IGFs from their binding proteins to help establish pregnancy and to enhance 
the growth and estrogen synthesis of the conceptus.  
The observation of multiple tissue kallikreins during embryonic development in the pig 
suggests that kallikreins may participate in a common enzymatic pathway that plays a 
role in the normal physiology of pregnancy. But, their diverse tissue expression patterns 
also suggest that the kallikrein gene family members may have different physiological 
substrates.  It is possible that several different uterine kallikrein genes may be involved in 
alteration of the extracellular matrix, embryo implantation and degradation of insulin like 
growth factor binding proteins in the porcine uterus. During this study we have 
established the expression of multiple tissue kallikreins in the porcine endometrium and 
conceptus suggesting that kallikreins may initiate many biological processors during 
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early conceptus attachment and survival. The expression of KLK1 during the estrous 
cycle and pregnancy, and the pregnancy specific expression of kinins in the porcine 
endometrium (Allen et al. 2002) suggests that KLK1 may be activated by the conceptus 
during embryonic attachment to the uterine epithelium. The activation of KLK1 will 
cleave LMW kininogen to release bradykinins, which will increase uterine blood flow, 
vascular permeability, prostaglandin release during early embryonic development in the 
pig. Embryo development is dependent upon the efficient transport of nutrients to the 
developing conceptus across the placenta. Therefore, the increased blood flow by the 
release of kinins through KLK1 would help conceptus development and embryonic 
survival in the pig. The greater expression of KLK4 during days 0-10 of the estrous 
cycle, and the ability of KLK4 to cleave a broad range of peptides suggests that  KLK4 
may play a role in extracellular matrix remodeling. Also, the greater expression of KLK4 
in the conceptus with respect to endometrial expression suggests that kallikrein 4 plays an 
important role in early conceptus development. The KLK4 expression in the conceptus is 
high during the time when the conceptus attaches to the uterine epithelium suggesting 
that KLK4 could play a role in opening sites for conceptus attachment. Therefore, KLK4 
may play a role in degrading antiadhesive molecules present in the uterine epithelial 
surface, allowing the conceptus to interact with adhesion molecules such as integrins, 
proteoglycans and heparin. These initial interactions may bring the conceptus closer to 
the uterine epithelium to complete conceptus attachment. The higher expression of 
KLK14 in cyclic and pregnant endometrium on days 0 and 12-18 is consistent with the 
time of IGF-BP degradation (Geisert et al. 2001). Therefore KLK14 may be degrading 
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IGF-BP enabling the release of IGF from it’s binding proteins to provide necessary 
growth factors for embryonic survival in the pig.  
Although this preliminary investigation shows the presence of multiple kallikreins during 
early embryonic development in the pig, a closer investigation of the porcine kallikrein 
gene family members and their expression patterns need to be carried out, to establish 
their substrate specificities, methods of activation, and their functional roles during 
establish pregnancy in the pig.  
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